Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1050.Time spend outdoors in summer,45676,-0.0165118006758316,0.047537395363322,-0.109685095587943,0.0766614942362796,0.728336698057849
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1060.Time spent outdoors in winter,42425,0.00775774634459111,0.0539965525657903,-0.0980754966843579,0.11359098937354,0.885761719908387
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X1070.Time spent watching television (TV),46741,-0.0526728264650734,0.0472506680006826,-0.145284135746411,0.0399384828162645,0.264967968029146
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X1080.Time spent using computer,42406,0.0848579864116486,0.0507402845824391,-0.0145929713699321,0.184308944193229,0.0944625952162236
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X1090.Time spent driving,41429,0.0701917727519813,0.0530687060946823,-0.033822891193596,0.174206436697559,0.185966202730423
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1160.Sleep duration,48284,-0.0336093197274331,0.0442649859128501,-0.120368692116619,0.0531500526617531,0.447695092581665
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32723,0.00409264496129649,0.00906430399577145,-0.0136733908704155,0.0218586807930085,0.651631392574066
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32723,-0.021664403722122,0.00890971290380419,-0.0391274410135782,-0.00420136643066578,0.0150540945235334
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32723,-0.0234585381899563,0.0104251184951336,-0.0438917704404182,-0.0030253059394944,0.0244610613749614
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32723,-0.00372234213743404,0.0107868202001114,-0.0248645097296524,0.0174198254547843,0.730040589933388
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32723,-0.0131078571805273,0.0110794929049052,-0.0348236632741415,0.00860794891308699,0.236811654844862
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32723,-0.0360586272784497,0.0211605455861069,-0.0775332966272192,0.00541604207031975,0.0884068026453826
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32723,-0.037538216863701,0.0215452187667068,-0.0797668456464464,0.00469041191904437,0.0814907941707332
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32723,-0.0383880826863443,0.0154873737039538,-0.0687433351460938,-0.0080328302265948,0.0132058085699803
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32723,-0.0158711921750556,0.0115300886097251,-0.0384701658501169,0.00672778150000561,0.168700983447725
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32723,-0.022012735955131,0.00812262808934422,-0.0379330870102457,-0.00609238490001632,0.00674023076408384
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32723,-0.00652045917401254,0.0114344877411576,-0.0289320551466814,0.0158911367986563,0.56852601077533
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32723,0.000140873390588456,0.0065685695172697,-0.0127335228632602,0.0130152696444371,0.982889894683228
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32723,-0.0171797252427861,0.00840920792542102,-0.0336617727766113,-0.00069767770896087,0.0410853290790564
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32723,-0.030288105805942,0.0127439123486835,-0.0552661740093616,-0.0053100376025223,0.0174907029453405
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32723,-0.0222229607678638,0.0118444960239261,-0.0454381729747589,0.000992251439031349,0.0606569805679812
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32723,-0.015154928667549,0.0146227670270044,-0.0438155520404776,0.0135056947053796,0.30004726026419
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32723,-0.0234106413980397,0.0141238514177711,-0.051093390176871,0.00427210738079164,0.0974487045819346
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32723,0.0036116200650842,0.00936814302265796,-0.0147499402593254,0.0219731803894938,0.699860371071777
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32723,-0.00438881925130812,0.00882460266971113,-0.0216850404839419,0.0129074019813257,0.618962336537823
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32723,-0.00980266054958455,0.010925146179436,-0.0312159470612792,0.0116106259621101,0.369606330130255
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120040.Fatigue severity over the past week,32732,-0.220279918346178,0.0779399379323327,-0.37304219669355,-0.0675176399988057,0.00471977228613266
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120041.Waking unrefreshed severity over the past week,32734,-0.22153494047581,0.077053142417661,-0.372559099614425,-0.0705107813371942,0.00404869609311164
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120042.Cognitive symptoms severity over the past week,32732,-0.230093104392061,0.0845253767797669,-0.395762842880404,-0.0644233659037177,0.00649799340993529
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120098.Mobility problems today,32736,-0.344624707018845,0.0927725865850823,-0.526458976725606,-0.162790437312084,0.000204672840559683
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120099.Self-care problems today,32736,-0.614105663444871,0.138460755738716,-0.885488744692754,-0.342722582196989,9.30808172422701e-06
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120100.Problems doing usual activities,32736,-0.212806489782192,0.088153137046017,-0.385586638392385,-0.0400263411719982,0.0157962086581452
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120101.Pain or discomfort today,32736,-0.197577655054057,0.0771701187284645,-0.348831087761847,-0.046324222346266,0.0104749821129197
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120102.Anxiety or depression today,32736,-0.233161914413435,0.0910944567690934,-0.411707049680858,-0.0546167791460122,0.0104968403293229
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120103.Scale to indicate how health is today,32703,0.0119110274207732,0.00281894009039454,0.00638590484359992,0.0174361499979465,2.40957394779361e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32719,-0.421744380874664,0.0911703266235732,-0.600438221056868,-0.243050540692461,3.78276524712178e-06
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32706,-0.271264269745192,0.0932496720030028,-0.454033626871078,-0.0884949126193068,0.0036347772279407
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32725,-0.199648719813098,0.0773201592182464,-0.351196231880861,-0.0481012077453352,0.0098358843666643
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32728,-0.343460279831685,0.0788993760773213,-0.498103056943235,-0.188817502720135,1.35705386257182e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32723,-0.442196270515592,0.0945015179512462,-0.627419245700035,-0.25697329533115,2.92194286472573e-06
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120109.Feeling bad about self over the last two weeks,32701,-0.0986725993801743,0.0976849910760151,-0.290135181889164,0.0927899831288154,0.312470177672614
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120110.Trouble concentrating over the last two weeks,32728,-0.346804513496992,0.0970407996882308,-0.537004480885924,-0.156604546108059,0.000353705286558746
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32717,-0.378211710846757,0.143146187081027,-0.658778237525569,-0.0976451841679448,0.00825298102452671
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32670,-0.214269908697931,0.190958802542802,-0.588549161681823,0.16000934428596,0.261861561778904
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30207,-0.204506247863021,0.101196786733083,-0.402851949859864,-0.00616054586617806,0.0433344292495336
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45557,-0.0903357346726124,0.101219207664273,-0.288725381694587,0.108053912349362,0.372147637817837
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,44390,0.051334329400739,0.0643145912963406,-0.0747222695400886,0.177390928341567,0.424777900766019
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1289.Cooked vegetable intake,47376,0.0924826465451681,0.0454566709017187,0.00338757157779949,0.181577721512537,0.0419100793242331
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46921,0.0866835677584429,0.0487822406028058,-0.00892962382305647,0.182296759339942,0.0755897626939026
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1309.Fresh fruit intake,47378,0.01837656858963,0.0486363605724285,-0.0769506981323299,0.11370383531159,0.705555828507474
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1319.Dried fruit intake,46048,-0.0683010423922663,0.051079308352644,-0.168416486763449,0.0318144019789159,0.181185181908191
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X134.Number of self-reported cancers,48485,-0.150804719346391,0.0987017405920387,-0.344260130906787,0.0426506922140047,0.1265544155392
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X135.Number of self-reported non-cancer illnesses,48485,-0.318102917546825,0.0449371874172214,-0.406179804884579,-0.230026030209071,1.49270621177683e-12
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X136.Number of operations, self-reported",48485,-0.146650181273997,0.0445820140858573,-0.234030928882277,-0.0592694336657167,0.0010052526261992
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X137.Number of treatments or medications taken,48485,-0.261572971748569,0.044500460822883,-0.34879387496142,-0.174352068535718,4.20644937827979e-09
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1438.Bread intake,47727,-0.00572029800323189,0.00181358658377219,-0.00927492770742538,-0.0021656682990384,0.00161173875796917
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1458.Cereal intake,47039,-0.0962279910709774,0.0459315491083164,-0.186253827323278,-0.00620215481867725,0.0361791165959385
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1488.Tea intake,47520,0.000353455035893793,0.00172100526018456,-0.00301971527406795,0.00372662534585553,0.837279292544085
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1498.Coffee intake,46486,0.0662604970910375,0.0461354318791348,-0.0241649493920666,0.156685943574142,0.150954395174039
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1528.Water intake,46755,0.0697859052780381,0.0472314018955242,-0.0227876424371893,0.162359452993266,0.139546856617764
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1568.Average weekly red wine intake,40528,0.35832032661266,0.0553445370395901,0.249845034015063,0.466795619210256,9.78762534598536e-11
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,40522,0.290586956095804,0.0567685221080585,0.179320652764009,0.401853259427599,3.10900012437229e-07
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1588.Average weekly beer plus cider intake,40565,0.0815069836174872,0.0617762233011684,-0.039574414052803,0.202588381287777,0.187056563978673
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1598.Average weekly spirits intake,40501,0.0135686348761486,0.0624172229430776,-0.108769122092283,0.135906391844581,0.827910150475744
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1608.Average weekly fortified wine intake,40557,0.0994207420814356,0.113353405719015,-0.122751933127833,0.321593417290704,0.380452275623342
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1737.Childhood sunburn occasions,42772,0.10893491987641,0.0537751243113721,0.0035356762261205,0.214334163526699,0.0428044963995016
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1807.Father's age at death,38610,0.0027354565939343,0.00240992255428022,-0.00198799161245494,0.00745890480032354,0.256359949306645
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1845.Mother's age,37860,0.00144645491974543,0.00365596723064448,-0.00571924085231775,0.00861215069180861,0.692375029224907
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1873.Number of full brothers,48042,-0.0946176077252293,0.0445950112617836,-0.182023829798325,-0.0072113856521334,0.033872378018176
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1883.Number of full sisters,48043,-0.13022351496024,0.044857487805208,-0.218144191058448,-0.0423028388620324,0.00369881988212149
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20015.Sitting height,48276,-0.0048725215354661,0.00229710781313673,-0.00937485284921409,-0.000370190221718102,0.0339188158696719
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20016.Fluid intelligence score,31702,0.0772156909515128,0.0735003793935501,-0.0668450526598454,0.221276434562871,0.293498566442736
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20018.Prospective memory result,32009,0.0229376648841337,0.10124295551279,-0.175498527920934,0.221373857689201,0.820771114484
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31627,-0.00409407644995609,0.00323521748952059,-0.0104351027294165,0.00224694982950427,0.205740217036757
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31635,-0.00592690244334416,0.00321011079992723,-0.0122187196112015,0.000364914724513202,0.0648832563301997
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20023.Mean time to correctly identify matches,48206,-0.00349069929759328,0.00182810032446476,-0.00707377593354421,9.23773383576481e-05,0.0562134713930756
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#1.Illnesses of father_Heart disease,45633,-0.00867237290034256,0.00395351701260015,-0.0164212662450389,-0.000923479555646263,0.0282758407745221
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45252,0.00440920356334361,0.00903798241212879,-0.0133052419644288,0.022123649091116,0.62565922355935
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45224,-0.0206395505171434,0.0120489813856818,-0.0442555540330797,0.00297645299879291,0.0867324630993719
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#12.Illnesses of father_Severe depression,45254,-0.0114742458919129,0.00918251369715951,-0.0294719727383456,0.00652348095451973,0.211468257948274
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45255,-0.00604336386770295,0.00672654630296452,-0.0192273946215134,0.0071406668861075,0.368963854744646
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#2.Illnesses of father_Stroke,45394,-0.00564275875033694,0.00519591658846316,-0.0158267552637247,0.00454123776305085,0.277491716360116
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45342,-0.0011175815679184,0.0067748513991025,-0.0143962903101593,0.0121611271743225,0.868976776401707
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45255,0.00686271246153951,0.00819288325376318,-0.00919533871583631,0.0229207636389153,0.402240512865055
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45374,-0.0151891486836263,0.00641747310772843,-0.0277673959747741,-0.00261090139247861,0.0179493634692616
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45494,-0.00157205265297333,0.00410167949149135,-0.00961134445629637,0.00646723915034972,0.701522993278749
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#9.Illnesses of father_Diabetes,45365,-0.0103087381848554,0.00556375535575474,-0.0212136986821347,0.000596222312423903,0.0639192504695854
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46556,-0.00468720385885022,0.00474094505530377,-0.0139794561672456,0.00460504844954517,0.322837878979857
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46446,-0.0122601882672934,0.00769995544341192,-0.0273521009363808,0.00283172440179392,0.11134445578617
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46397,-0.0100399274612547,0.0164743621255447,-0.0423296772273222,0.0222498223048129,0.542247333055832
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46439,-0.00772219066568691,0.00692183623868098,-0.0212889896935016,0.00584460836212781,0.264593500805161
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#2.Illnesses of mother_Stroke,46500,-0.0093491938736453,0.00565329671955444,-0.020429655443972,0.0017312676966814,0.0981902256657723
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46442,0.00756448702184033,0.00919260910664308,-0.0104530268271801,0.0255820008708608,0.410580419993208
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46419,-0.0075163916115225,0.00866000082526401,-0.02448999322904,0.00945721000599496,0.38543448469385
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46451,-0.00224033733767894,0.00659697855496713,-0.0151704153054145,0.0106897406300566,0.734160544591394
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46457,-0.0233645225691176,0.00775519286688259,-0.0385647005882074,-0.00816434455002767,0.00259171506273123
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46650,-0.000863404291028991,0.00373624441168213,-0.00818644333792596,0.00645963475586798,0.817247879339677
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46504,-0.0165367326264603,0.00577227375241808,-0.0278503891811997,-0.00522307607172082,0.00417582771746474
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,44053,-0.0182581396586569,0.0076431117509351,-0.0332386386904897,-0.00327764062682416,0.0169109756237852
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43955,0.00348972680379651,0.0438005847983385,-0.082359419400947,0.08933887300854,0.936498076362446
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43954,-0.0239566745428547,0.0371221223955715,-0.0967160344381749,0.0488026853524655,0.518709286932897
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,44032,-0.000673675194125578,0.00702980242705838,-0.01445208795116,0.0131047375629088,0.923655499861678
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43958,-0.0515446932025006,0.024033757380829,-0.0986508576689254,-0.00443852873607582,0.0319904789616292
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43973,-0.0153910121792138,0.0131847716843322,-0.0412331646805049,0.0104511403220773,0.243089966983131
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43958,0.00740949145878947,0.0173013140686395,-0.0265010841157439,0.0413200670333228,0.668465135197901
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43970,-0.0163500006979793,0.015753782033209,-0.0472274134830688,0.0145274120871103,0.299354205209759
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43971,-0.00187412893239509,0.0104828231391289,-0.0224204622850878,0.0186722044202976,0.858111515891085
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43976,-0.0200461429690381,0.0139106271871055,-0.0473109722557649,0.00721868631768872,0.149581377828669
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,44134,-0.0124261604396947,0.00492405879187534,-0.0220773156717703,-0.002775005207619,0.0116248828971352
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,44039,-0.0297378128570106,0.00718051954869872,-0.0438116311724601,-0.0156639945415611,3.46510233289786e-05
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20127.Neuroticism score,43585,-0.0553090665909743,0.0463359534715354,-0.146127535395184,0.0355094022132352,0.232627954988899
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,31702,0.0109445201805339,0.0753764384175832,-0.136793299117929,0.158682339478997,0.884558155289698
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X20161.Pack years of smoking,30750,-0.0156412492929993,0.00375378678655562,-0.0229986713946483,-0.00828382719135025,3.12693146144547e-05
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30750,-0.0146863195152955,0.00350790226896536,-0.0215618079624676,-0.00781083106812337,2.86641081952809e-05
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20191.Fluid intelligence score,30186,0.192625148570006,0.0858146873296621,0.0244283614038683,0.360821935736144,0.0248241897498889
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30186,0.153717118577179,0.0877059276164985,-0.0181864995511576,0.325620736705517,0.079711957998419
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20240.Maximum digits remembered correctly,29627,-0.0320930647972101,0.0912235301422075,-0.210891183875937,0.146705054281517,0.72499597593643
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20255.Spirometry QC measure,42159,-0.068002546668553,0.0601898972425923,-0.185974745264034,0.0499696519269279,0.258575310352357
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X20261.avMSE,29234,-0.00400298695034196,0.00406040148163129,-0.0119613738543393,0.00395539995365536,0.324246255831355
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X20262.Myopia diagnosis,29234,0.0943671181563887,0.108118262053309,-0.117544675468097,0.306278911780875,0.382803544414256
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X20280.Glucose-lactate,37413,0.00478722918443558,0.00237233871580525,0.000137445301457295,0.00943701306741387,0.0436175279016832
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X20281.Spectrometer-corrected alanine,37441,-0.000889106593907463,0.00234699387113421,-0.00548921458133052,0.00371100139351559,0.704821641993743
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31511,-0.000501149702157129,0.0111418423554168,-0.0223391607187741,0.0213368613144598,0.964125165976477
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31509,-0.0088070313215167,0.022512383580927,-0.0529313031401336,0.0353172404971002,0.695654169852327
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31509,-0.0165846859757289,0.0250701470527204,-0.0657221741990609,0.0325528022476032,0.508291600638677
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31509,0.00651232813003829,0.0107828650770445,-0.014622087420969,0.0276467436810456,0.545893762050952
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31509,0.0261353493535893,0.0170838306899328,-0.00734895879867902,0.0596196575058576,0.12610027233427
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31513,0.0101648225526319,0.0221649157937521,-0.0332784124031221,0.053608057508386,0.646534713115618
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31513,-0.0031744283541283,0.0149200232799434,-0.0324176739828174,0.0260688172745608,0.831517520652548
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31513,-0.0184881707268708,0.0161857396138204,-0.0502122203699587,0.0132358789162172,0.253385605378736
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31513,0.011651047212225,0.0251355355538842,-0.037614602473388,0.060916696897838,0.64299848490161
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31513,0.00573501113353064,0.0284544856274019,-0.0500357806961771,0.0615058029632383,0.840273631273956
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31513,0.00194545912193753,0.0168281673669017,-0.0310377489171898,0.0349286671610648,0.907966804203206
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31513,0.0362894461364037,0.0284507813059836,-0.0194740852233242,0.0920529774961316,0.202165139256616
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31513,0.0273845206943918,0.0213194371378474,-0.0144015760957891,0.0691706174845726,0.199010803056059
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31516,0.00250024868891598,0.0291144176290541,-0.05456400986403,0.059564507241862,0.931566718154339
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31516,-0.00273460346743768,0.0145107458182051,-0.0311756652711196,0.0257064583362442,0.850526016708455
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31516,0.0211201343120786,0.0196978082276312,-0.0174875698140786,0.0597278384382358,0.283660716186826
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31516,0.0234004362825731,0.0326249378592114,-0.0405444419214812,0.0873453144866273,0.473237960250492
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20600.Liking for adding salt to foods,33475,-0.0463780598521764,0.0692910588813886,-0.182188535259698,0.0894324155553452,0.503305908264769
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20601.Liking for aniseed,33475,-0.0199582266271208,0.0696773873122079,-0.156525905759048,0.116609452504807,0.774549123780439
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20602.Liking for apple juice,33475,-0.0912277321857207,0.0697565083935775,-0.227950488637133,0.0454950242656911,0.190971621422757
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20603.Liking for apples,33475,-0.00112623106974993,0.0710150642147423,-0.140315756930645,0.138063294791145,0.987347172929083
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20604.Liking for asparagus,33475,0.297016241932554,0.0705563480811965,0.158725799693409,0.4353066841717,2.58116933888457e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20605.Liking for aubergine,33475,0.242623501936772,0.0695670187734746,0.106272145140762,0.378974858732782,0.000489516191514588
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20606.Liking for avocados,33475,0.217841774967801,0.0706758118051499,0.0793171838297071,0.356366366105895,0.00206011768071386
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20607.Liking for bacon,33475,0.129016739407021,0.0700446540390275,-0.00827078250947302,0.266304261323515,0.0655174701543367
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20608.Liking for baked or steamed fish,33475,0.171102945149423,0.0702395224094809,0.03343348122684,0.308772409072005,0.0148690473861531
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20609.Liking for bananas,33475,-0.145398279442303,0.0719647508386089,-0.286449191085977,-0.00434736779862968,0.043368606861178
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33475,0.216988308210155,0.0693550015798415,0.0810525051136657,0.352924111306645,0.00176129987498848
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20611.Liking for beef steak,33475,0.234585449286138,0.069757681120087,0.097860394290767,0.371310504281508,0.000774403063162153
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20612.Liking for beetroot,33475,-0.0875143986505306,0.0707686364826004,-0.226220926156427,0.0511921288553662,0.216255866371333
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20613.Liking for bell pepper,33475,0.0932991460005282,0.0700043888257386,-0.0439094560979194,0.230507748098976,0.182641732860921
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20614.Liking for bicycling,33475,0.192524669252496,0.0694548925139673,0.05639307992512,0.328656258579872,0.00558309006288226
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20615.Liking for biscuits,33475,-0.328669491629382,0.0696824458015848,-0.465247085400488,-0.192091897858276,2.43108922190354e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20616.Liking for bitter foods,33475,0.205332695348572,0.069467564315514,0.0691762692901643,0.341489121406979,0.00312610184548035
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20617.Liking for bitter or ale,33475,0.363993136080605,0.0710377453526923,0.224759155189328,0.503227116971882,3.05032708976615e-07
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20618.Liking for black olives,33475,0.234640324052014,0.0704624551756925,0.0965339119076568,0.372746736196371,0.000871715818916482
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20619.Liking for black pepper,33475,0.201002304320419,0.070506303968243,0.0628099485426626,0.339194660098175,0.00436965950641557
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20620.Liking for blue cheese,33475,0.199263018433898,0.0698215241704998,0.0624128310597188,0.336113205808078,0.00432797277161031
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20621.Liking for bolognese sauce,33475,0.166930694727576,0.0700795978462829,0.0295746829488621,0.304286706506291,0.0172375173632838
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20622.Liking for broad beans,33475,0.0593719100803225,0.0692587968325251,-0.0763753317114267,0.195119151872072,0.391329664477006
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20623.Liking for broccoli,33475,0.141834118905077,0.0722985829619565,0.000128896299641801,0.283539341510511,0.0498166075414285
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20624.Liking for brown rice,33475,0.0141977993484765,0.0700776525032207,-0.123154399557836,0.151549998254789,0.839451233918652
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20625.Liking for brussel sprouts,33475,-0.0338039844026385,0.0706808615240947,-0.172338472989864,0.104730504184587,0.632474479982598
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20626.Liking for burgers (meat),33475,0.151202856744525,0.0693301684977215,0.015315726488991,0.287089987000059,0.0292142483669463
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20627.Liking for burn of spicy foods,33475,0.268330626456612,0.0689828767067337,0.133124188111413,0.40353706480181,0.000100997318733753
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20628.Liking for butter on bread,33475,-0.109686598108912,0.0710932859399728,-0.249029438551259,0.0296562423334342,0.122899015998979
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20629.Liking for butternut squash,33475,0.0524905971559247,0.069808318486413,-0.0843337070774447,0.189314901389294,0.452114781297731
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20630.Liking for cabbage,33475,0.0499939405618917,0.0701081767937495,-0.0874180859538574,0.187405967077641,0.475802969622497
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20631.Liking for cake,33475,-0.260454240227086,0.0703913752356331,-0.398421335688927,-0.122487144765246,0.00021672891882078
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20632.Liking for cake icing,33475,-0.243741681099802,0.0690339135405935,-0.379048151639365,-0.108435210560238,0.000416320199782764
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20633.Liking for capers,33475,0.125906458904024,0.0692469958944146,-0.00981765304902887,0.261630570857076,0.0690612341917767
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20634.Liking for cauliflower,33475,0.0752916960613402,0.0710675655807804,-0.0640007324769894,0.21458412459967,0.289426883604777
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20635.Liking for cereal or granola bar,33475,-0.0511570087377308,0.0691540759050718,-0.186698997511672,0.0843849800362098,0.459467313847016
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20636.Liking for cheesecake,33475,-0.16669753818243,0.0698246422854965,-0.303553837062003,-0.0298412393028572,0.0169884363414544
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20637.Liking for cherries,33475,-0.0689594108238624,0.0727856544524358,-0.211619293550637,0.0737004719029118,0.343442855177729
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20638.Liking for chicken,33475,0.186465501528159,0.0728667240254655,0.0436467224382471,0.329284280618072,0.0105127435971175
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20639.Liking for chilli pepper,33475,0.237999053785995,0.0695814157916897,0.101619478834283,0.374378628737707,0.000627801161624412
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20640.Liking for chips or french fries,33475,-0.0646823635108774,0.0699793153446987,-0.201841821586487,0.072477094564732,0.355349772637494
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20641.Liking for cigarette smoking,33475,-0.110356015607801,0.107940184069602,-0.321918776384222,0.101206745168619,0.306626258058887
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20642.Liking for cod,33475,0.0602487330027353,0.0715027813052807,-0.0798967183556148,0.200394184361085,0.399469339740698
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20643.Liking for coffee with sugar,33475,-0.205681408847898,0.0759338765115272,-0.354511806810492,-0.0568510108853051,0.00676689095747658
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20644.Liking for coffee without sugar,33475,0.220099032581013,0.0710998146228633,0.0807433959202008,0.359454669241825,0.00196957445422693
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20645.Liking for coriander,33475,0.241904562949519,0.0693480429330315,0.105982398800777,0.377826727098261,0.000488337286942612
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20646.Liking for corn flakes,33475,-0.281784770449653,0.0697527974552871,-0.418500253462016,-0.145069287437291,5.39217873608963e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20647.Liking for cream,33475,-0.090221318567892,0.0695027027526497,-0.226446615963085,0.0460039788273015,0.194284831790774
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20648.Liking for croissant,33475,-0.0201508635547421,0.0696558350875266,-0.156676300326294,0.11637457321681,0.7723643118896
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20649.Liking for cucumber,33475,0.0127899975569138,0.0703095330741133,-0.125016687268348,0.150596682382176,0.855657302097578
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20650.Liking for curry,33475,0.218583712504854,0.0710591724854115,0.0793077344334478,0.357859690576261,0.00210331076718249
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20651.Liking for dairy products,33475,-0.028530529718055,0.070646685049722,-0.16699803241551,0.1099369729794,0.686333411106439
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20652.Liking for dark chocolate,33475,0.0280434720274549,0.0700402952799116,-0.109235506721172,0.165322450776082,0.688877790693623
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20653.Liking for diet fizzy drinks,33475,-0.0722397959716798,0.0710516268520236,-0.211500984601646,0.0670213926582864,0.309311010000887
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20654.Liking for dried fruit,33475,0.0330515740184523,0.0698152820491667,-0.103786378797915,0.169889526834819,0.63592817161713
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20655.Liking for eggs,33475,0.0733889128758799,0.0718845032184294,-0.0675047134322418,0.214282539184002,0.307314191485567
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20656.Liking for exercising alone,33475,0.133762447511487,0.0692638262989907,-0.00199465203453494,0.269519547057509,0.0534874490653628
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20657.Liking for exercising with others,33475,0.269671542289266,0.0691396725336835,0.134157784123246,0.405185300455286,9.66931305157313e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20658.Liking for extra virgin olive oil,33475,0.161271632343694,0.0707336481642205,0.0226336819418221,0.299909582745566,0.022630416037289
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20659.Liking for fatty foods,33475,0.00367281654894591,0.069245530631108,-0.132048423488026,0.139394056585918,0.957700753429139
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20660.Liking for fresh tomatoes,33475,0.0123766634110485,0.074754481744621,-0.134142120808409,0.158895447630506,0.868503433651996
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20661.Liking for fried chicken,33475,-0.0179531171309255,0.068890715132281,-0.152978918790196,0.117072684528345,0.794404372809648
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20662.Liking for fried or battered fish,33475,-0.0303298724877025,0.0695096389173117,-0.166568764765633,0.105909019790228,0.662599488172136
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20663.Liking for fruit,33475,-0.0647237353754141,0.0766679263380756,-0.214992870998042,0.0855454002472141,0.398573780876409
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20664.Liking for garlic,33475,0.214946029695395,0.0709992099004813,0.0757875782904519,0.354104481100339,0.00247286623756161
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20665.Liking for gherkins,33475,0.118902331337774,0.0691408855842336,-0.0166138044073237,0.254418467082872,0.0855172254719705
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20666.Liking for globe artichoke,33475,0.181420851005142,0.0699459604916811,0.0443267684414473,0.318514933568837,0.00950854245990806
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20667.Liking for goat's cheese,33475,0.224370119846888,0.0697221373469101,0.087714730646944,0.361025509046832,0.00129488545943482
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20668.Liking for going to a cafe,33475,-0.193697909426232,0.0704102793725252,-0.331702056996382,-0.0556937618560829,0.00595269345321874
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20669.Liking for going to the gym,33475,0.221882582878725,0.0690136594769037,0.0866158103039942,0.357149355453457,0.0013085176183131
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20670.Liking for going to the pub,33475,0.516328726550235,0.0692221874294253,0.380653239188561,0.652004213911908,9.47329288892758e-14
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20671.Liking for grapefruit,33475,0.0208250920059793,0.0695560660199691,-0.11550479739316,0.157154981405119,0.764641275524905
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20672.Liking for green olives,33475,0.246573009664463,0.0705022133272028,0.108388671543146,0.38475734778578,0.000471977015841582
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20673.Liking for haddock,33475,0.191419139075456,0.0710063278528574,0.0522467364838553,0.330591541667056,0.00703412951319093
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20674.Liking for ham,33475,0.118756005773512,0.0697371536599793,-0.0179288154000471,0.255440826947072,0.0886175055118619
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20675.Liking for hard cheese,33475,0.100177397138103,0.0713345211848302,-0.0396382643841637,0.239993058660371,0.160252147321798
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20676.Liking for herring,33475,0.232590940622368,0.0690537163561661,0.0972456565642826,0.367936224680454,0.000759412405846914
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20677.Liking for honey,33475,-0.0161700165147156,0.0697790273285725,-0.152936910078718,0.120596877049287,0.816751301130995
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20678.Liking for horseradish or wasabi,33475,0.217570496108144,0.0692691830629653,0.0818028973047316,0.353338094911556,0.00168916450802692
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20679.Liking for ice cream,33475,-0.20680668429376,0.0704606270399188,-0.344909513292001,-0.0687038552955191,0.00334265111921127
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20680.Liking for jam,33475,-0.257992026012184,0.0697360410041897,-0.394674666380396,-0.121309385643972,0.000217186987140426
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20681.Liking for kiwi fruit,33475,-0.0352341643261073,0.0697772133526019,-0.171997502497207,0.101529173844992,0.613603923319113
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20682.Liking for lager,33475,0.219261365034013,0.0696903566953625,0.0826682659111023,0.355854464156923,0.00165899280525385
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20683.Liking for lamb,33475,0.20684740641198,0.0696908193955842,0.0702534003966352,0.343441412427325,0.00300412856822549
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20684.Liking for lemons,33475,-0.0246413163859163,0.0703123704544305,-0.1624535624766,0.113170929704767,0.726004998060987
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20685.Liking for lentils or beans,33475,-0.010803243691751,0.0702610507623308,-0.148514903185919,0.126908415802417,0.877803275398838
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20686.Liking for liver,33475,0.201856076025464,0.0698972123178884,0.0648575398824027,0.338854612168525,0.00388690601683715
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20687.Liking for mackerel,33475,0.326168137785144,0.0694166763175805,0.190111452202687,0.462224823367602,2.65459563385656e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20688.Liking for marzipan,33475,-0.0710668464987458,0.069268638377072,-0.206833377717807,0.0646996847203153,0.304936311916009
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20689.Liking for mayonnaise,33475,0.126854217195458,0.069202445266622,-0.00878257552712131,0.262491009918037,0.0668203178305772
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20690.Liking for melon,33475,0.0113160815954016,0.0715726365198221,-0.12896628598345,0.151598449174253,0.874376394353929
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20691.Liking for milk chocolate,33475,-0.15054097799101,0.0697816263962067,-0.287312965727576,-0.0137689902544454,0.031005816815632
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20692.Liking for mushrooms,33475,0.112909591661713,0.0715339400440693,-0.0272969308246626,0.253116114148089,0.114505321956157
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20694.Liking for orange juice,33475,-0.0672268847665451,0.0697669665905519,-0.203970139284027,0.0695163697509366,0.335274819068879
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20695.Liking for oranges,33475,-0.102991774976453,0.0711994301743353,-0.24254265811815,0.0365591081652443,0.148062557209853
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20696.Liking for pasta,33475,0.0987859396430122,0.0702597995556011,-0.0389232674859659,0.23649514677199,0.159753673899391
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20697.Liking for pears,33475,-0.161026137169884,0.0709710385489724,-0.30012937272587,-0.0219229016138985,0.0232965369089463
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20698.Liking for pizza,33475,0.0168441937556645,0.0694403478422921,-0.119258888015228,0.152947275526557,0.808343160434192
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20699.Liking for plain yogurt,33475,0.122271547120677,0.0694504944162866,-0.0138514219352447,0.258394516176599,0.0783452464646484
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20700.Liking for plums,33475,-0.00483450495560715,0.0707446160933402,-0.143493952498554,0.13382494258734,0.945518454568885
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20701.Liking for pollock,33475,0.221172316571137,0.0690719006956032,0.0857913912077549,0.35655324193452,0.00136893575010643
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20702.Liking for pork chop,33475,0.195208089657366,0.0691380199274283,0.0596975705996063,0.330718608715125,0.00476068473765663
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20703.Liking for porridge,33475,-0.0321150746089547,0.0706338471998512,-0.170557415120663,0.106327265902754,0.649357110932315
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20704.Liking for potato crisps,33475,-0.178946367801056,0.0696009015543198,-0.315364134847523,-0.0425286007545895,0.0101544156206389
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20705.Liking for potatoes,33475,-0.0820962038612394,0.0709288430269597,-0.22111673619408,0.0569243284716016,0.247119551387535
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20706.Liking for prawns,33475,0.299845182263247,0.0701328296381147,0.162384836172542,0.437305528353952,1.92647030884716e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20707.Liking for raw carrots,33475,0.124329250802119,0.0703185753771359,-0.0134951569370674,0.262153658541305,0.0770783538029428
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20708.Liking for red meat,33475,0.160286235868963,0.0698701007832804,0.0233408383337334,0.297231633404192,0.0218085034646704
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20709.Liking for red wine,33475,0.463034203604123,0.0702057699947557,0.325430894414402,0.600637512793844,4.46490348779402e-11
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33475,-0.111760559326783,0.0712027475317357,-0.251317944488984,0.0277968258354193,0.116538758951859
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20711.Liking for roast chicken,33475,0.154755928691204,0.0730346983358688,0.0116079199529009,0.297903937429507,0.0341213777664581
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20712.Liking for salad dressing,33475,0.027118450758137,0.0694792268371331,-0.109060833842644,0.163297735358918,0.696315837996689
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20713.Liking for salad leaves,33475,0.103015884167587,0.0718566822035946,-0.0378232129514586,0.243854981286632,0.15171046931442
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20714.Liking for salami,33475,0.282955506999456,0.0695404677388578,0.146656190231295,0.419254823767617,4.76067993448108e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20715.Liking for salmon,33475,0.222305262707171,0.072225083854331,0.0807440983526822,0.36386642706166,0.00209016509912764
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20716.Liking for salty foods,33475,-0.0946680166262882,0.0692351706176341,-0.230368951036851,0.0410329177842747,0.171550758756759
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20717.Liking for salty pretzels,33475,0.00538148315472221,0.069236929296831,-0.130322898267067,0.141085864576511,0.938047933933429
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20718.Liking for sardines,33475,0.225352001978312,0.0692361595132162,0.0896491293324086,0.361054874624216,0.00113852571791683
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20719.Liking for sausages (meat),33475,0.150104825493458,0.0694839062211003,0.0139163693001019,0.286293281686815,0.0307755041301077
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20720.Liking for savoury biscuits,33475,-0.0373623772114911,0.0701688778362879,-0.174893377770615,0.100168623347633,0.594417223023281
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33475,0.371141501859142,0.0691884774682756,0.235532086021322,0.506750917696962,8.31944913789479e-08
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20722.Liking for skimmed milk,33475,0.215508743647649,0.0696869925078413,0.0789222383322797,0.352095248963018,0.00199030691836949
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20723.Liking for smoked fish,33475,0.276318731129567,0.0698185629589025,0.139474347730118,0.413163114529016,7.62299146296261e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20724.Liking for soft cheese,33475,0.132150796550028,0.069523402746903,-0.00411507283390228,0.268416665933958,0.0573567736209918
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20725.Liking for soy sauce,33475,-0.0210255330227361,0.0698032135147419,-0.15783983151163,0.115788765466158,0.763259714697546
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20726.Liking for soya milk,33475,-0.0759301440293903,0.0697411868041723,-0.212622870165568,0.0607625821067874,0.276295084333564
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20727.Liking for spicy foods,33475,0.268049360037377,0.0699085156423273,0.131028669378415,0.405070050696338,0.000126733100934118
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20728.Liking for spinach,33475,0.214615817364846,0.0703492788576533,0.0767312308038453,0.352500403925846,0.00228917440701693
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20729.Liking for spirits,33475,0.296401580580663,0.0693018048733602,0.160570043028877,0.432233118132449,1.91289695194123e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20730.Liking for strawberries,33475,-0.0492913090339496,0.0756710019320517,-0.197606472820771,0.0990238547528717,0.514810559202712
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33475,-0.104747956055089,0.0712863742604929,-0.244469249605655,0.034973337495477,0.141757996699996
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20732.Liking for sweet foods,33475,-0.436076752733996,0.0699345468364877,-0.573148464533512,-0.29900504093448,4.69300853952142e-10
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20733.Liking for taking the stairs,33475,0.17725784679944,0.0710786589314325,0.0379436752938325,0.316572018305048,0.0126541130385047
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20734.Liking for tea with sugar,33475,-0.221856286932042,0.0833523338349724,-0.385226861248588,-0.0584857126154965,0.007788379503398
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20735.Liking for tea without sugar,33475,0.151744885979124,0.0727051084875782,0.00924287334347032,0.294246898614777,0.0369028365621827
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20736.Liking for tomato ketchup,33475,-0.108145823556503,0.0693258026847503,-0.244024396818613,0.0277327497056078,0.118801102410688
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20737.Liking for tinned tuna,33475,0.0951326306813343,0.0696983283039982,-0.0414760927945022,0.231741354157171,0.172310215257854
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20738.Liking for turnip (white),33475,0.0060314218604822,0.0698667195428265,-0.130907348443458,0.142970192164422,0.931207847553655
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20739.Liking for vegetables,33475,0.100329607696459,0.077127666991358,-0.0508406196066026,0.251499834999521,0.193349520098007
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20740.Liking for vinegar,33475,-0.0131302797387566,0.0695824610330239,-0.149511903363483,0.12325134388597,0.850331156785656
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20741.Liking for watching television,33475,-0.0687124716849224,0.0702893257095544,-0.206479550075649,0.0690546067058043,0.328313520198368
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20742.Liking for whisky,33475,0.374790075195263,0.073075421736502,0.231562248591719,0.518017901798807,2.97265666185905e-07
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20743.Liking for white bread,33475,-0.0418198117923534,0.0692550326024482,-0.177559675693152,0.0939200521084451,0.545956093378273
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20744.Liking for white rice,33475,-0.00582011229273791,0.0696045166230439,-0.142244964873904,0.130604740288428,0.933362790507214
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20745.Liking for white wine,33475,0.460143484137971,0.069615869137006,0.323696380629439,0.596590587646502,4.05425348935804e-11
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33475,0.0132118795713543,0.0701192455890128,-0.124221841783111,0.150645600925819,0.850551276390374
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20747.Liking for whole milk,33475,-0.0283783963615437,0.0694086686893423,-0.164419386992655,0.107662594269567,0.682651857129332
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20748.Liking for wholemeal bread,33475,-0.0275889710393856,0.0722563640214287,-0.169211444521386,0.114033502442615,0.702602855010528
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20749.Liking for working up a sweat,33475,0.219977305334306,0.0693838702021024,0.0839849197381857,0.355969690930427,0.00152687126218099
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X21001.Body mass index (BMI),48365,0.0273892802387863,0.00719574478762386,0.0132856204550435,0.041492940022529,0.000141395128669075
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X21002.Weight,48384,-0.00697667343090516,0.00421871558356466,-0.0152453559746919,0.00129200911288157,0.0981924408278998
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X21021.Pulse wave Arterial Stiffness index,31939,-0.00265437918698779,0.00334371757241052,-0.00920806562891242,0.00389930725493683,0.427311475075127
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,33007,-0.135643727318353,0.0740158567520327,-0.280714806552337,0.00942735191563135,0.0668900236686225
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,33007,0.0222000289292497,0.0772848697663552,-0.129278315812806,0.173678373671306,0.773927907634035
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,33008,0.0372457477815094,0.0762825233970685,-0.112267998076745,0.186759493639764,0.625376998609735
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21040.Satisfaction with bowel habits,32980,-0.0160197482680246,0.0711042398374283,-0.155384058349384,0.123344561813335,0.821751357095145
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32982,-0.23555251451313,0.0750339499113013,-0.382619056339281,-0.0884859726869795,0.00169904866702271
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21042.Greatest number of times bowels opened per day,32972,-0.132582165450976,0.07714986097015,-0.28379589295247,0.0186315620505184,0.0857391213542013
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21043.Least number of times bowels opened per week,32917,0.075116769370383,0.0758707453364033,-0.0735898914889675,0.223823430229733,0.322170090216438
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21044.Average number of times bowels opened per day,32953,-0.0760491690828795,0.0845242697641992,-0.24171673782071,0.089618399654951,0.368286870191467
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,33012,0.139889461137159,0.0769830024949409,-0.0109972237529251,0.290776146027243,0.0692272428865098
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,33006,0.11631907961224,0.0772013316740563,-0.0349955304689102,0.267633689693391,0.131922665916917
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29217,-0.223662634084115,0.115700614267077,-0.450435838047587,0.00311056987935618,0.0532746337240772
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,33009,0.270981639603032,0.0812727263629202,0.111687095931708,0.430276183274355,0.000858770797232956
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,33007,0.378964563000762,0.112488300862103,0.15848749331104,0.599441632690483,0.00075773912486854
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,33010,0.119672759350043,0.0911456337903178,-0.0589726828789802,0.298318201579066,0.189221268625557
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,33008,0.126677643699981,0.220827344415841,-0.306143951355067,0.559499238755029,0.566218658067144
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,33010,0.27325927917628,0.0860449621032131,0.104611153453983,0.441907404898578,0.00149933763951656
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,33010,0.392499303508096,0.0899212057457173,0.21625374024649,0.568744866769701,1.2856357744752e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32787,-0.22727939971268,0.0809531425656868,-0.385947559141426,-0.0686112402839336,0.0050029395762754
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,33010,0.112661356059642,0.0799895288380797,-0.0441181204629937,0.269440832582278,0.159031458091182
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,33011,0.0277571871664446,0.109861673320603,-0.187571692541938,0.243086066874827,0.80053989435451
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,33010,0.357997897710313,0.077137861397484,0.206807689371244,0.509188106049382,3.51525849787884e-06
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,33009,0.132252511653331,0.0768869095614326,-0.0184458310870771,0.282950854393738,0.0854496500270482
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X21100.Water hardness (USGS classification),48163,0.0220432412714368,0.045497631063446,-0.0671321156129174,0.111218598155791,0.628041060305854
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2139.Age first had sexual intercourse,45753,-0.0017980839150484,0.00194328080174858,-0.00560691428647563,0.00201074645637882,0.354829125383716
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2149.Lifetime number of sexual partners,43984,0.0650618959865215,0.051329182987986,-0.0355433026699312,0.165667094642974,0.204976217896093
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22032.IPAQ activity group,43990,0.169353645637179,0.0491314596057027,0.0730559848100013,0.265651306464356,0.000568113169754277
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22033.Summed days activity,44502,0.00656735388882212,0.00186960806168916,0.00290292208791137,0.0102317856897329,0.000444542403374651
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22034.Summed minutes activity,43990,0.00748806949996737,0.00190281601199152,0.003758550116464,0.0112175888834707,8.33869679141252e-05
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22037.MET minutes per week for walking,43307,0.00496508390131723,0.00186943290958189,0.00130099539853672,0.00862917240409774,0.00791544132752934
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22038.MET minutes per week for moderate activity,43990,0.00305305420795629,0.00195238438234704,-0.000773619181443915,0.0068797275973565,0.117890430005055
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22039.MET minutes per week for vigorous activity,43990,0.243277361733005,0.0493679338108462,0.146516211463746,0.340038512002264,8.38033467579036e-07
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22040.Summed MET minutes per week for all activity,43307,0.0073149205886832,0.00192292307235246,0.00354599136687238,0.011083849810494,0.000142777371734055
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X2217.Age started wearing glasses or contact lenses,43475,0.00197201001662803,0.0022336023098783,-0.00240585051073344,0.00634987054398951,0.377310186393156
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X22501.Year ended full time education,30132,0.0377276073304839,0.00938647386320154,0.0193301185586089,0.0561250961023589,5.9040258956393e-05
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X22506.Tobacco smoking,30091,0.0650213501652179,0.181522826352346,-0.29076338948538,0.420806089815816,0.720206305495975
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46703,0.214843181925089,0.102050052459184,0.0148250791050883,0.414861284745091,0.0352784730226249
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23098.Weight,48057,-0.00769478212441349,0.00424920574131681,-0.0160232253773944,0.000633661128567455,0.0701725385053145
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23099.Body fat percentage,48035,0.0321317201640474,0.00410839643389988,0.0240792631536037,0.0401841771744912,5.45426630352593e-15
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23100.Whole body fat mass,48004,0.0151316950387341,0.00390796162726502,0.00747209024929463,0.0227912998281735,0.000108222561956844
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23101.Whole body fat-free mass,48053,-0.025486570039375,0.00362718820456689,-0.0325958589203261,-0.0183772811584239,2.17336287870605e-12
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23102.Whole body water mass,48057,-0.0260138311147498,0.00362737101186365,-0.0331234782980026,-0.0189041839314971,7.62915336073757e-13
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23104.Body mass index (BMI),48057,0.026288679217248,0.00725802147175864,0.0120629571326011,0.0405144013018949,0.000292912181755786
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23105.Basal metabolic rate,48055,-0.0246940030522713,0.003887116742212,-0.0323127518670068,-0.0170752542375357,2.15218277948751e-10
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23106.Impedance of whole body,48054,0.0250911443461341,0.0029765790961323,0.0192570493177147,0.0309252393745534,3.66159088470925e-17
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23107.Impedance of leg (right),48054,0.0210238553485313,0.00245762472271237,0.016206910892015,0.0258407998050475,1.25243980440822e-17
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23108.Impedance of leg (left),48053,0.020864001171476,0.00243491162819212,0.0160915743802195,0.0256364279627326,1.10820106748027e-17
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23109.Impedance of arm (right),48048,0.016210473250756,0.00299056012259234,0.010348975410475,0.022071971091037,5.9984807983728e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23110.Impedance of arm (left),48052,0.0176528190577228,0.00298704576332115,0.0117982093616134,0.0235074287538323,3.47128416802053e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23111.Leg fat percentage (right),48053,0.0427172745818084,0.00507532851448083,0.032769630693426,0.0526649184701908,4.08566889023236e-17
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23112.Leg fat mass (right),48052,0.0228163761610947,0.00524850427166336,0.0125293077886345,0.0331034445335549,1.38439678736897e-05
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23113.Leg fat-free mass (right),48052,-0.0267091431433206,0.00390182788174351,-0.0343567257915379,-0.0190615604951033,7.81452596948435e-12
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23114.Leg predicted mass (right),48051,-0.0269510122674185,0.00391926845134397,-0.0346327784320527,-0.0192692461027844,6.28154933856936e-12
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23115.Leg fat percentage (left),48050,0.0434952992609,0.00524273020962705,0.033219548050031,0.053771050471769,1.12935689621721e-16
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23116.Leg fat mass (left),48050,0.0240606266196963,0.00545429316806454,0.0133702120102898,0.0347510412291028,1.03186256857683e-05
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23117.Leg fat-free mass (left),48048,-0.026856335131161,0.00404784434187464,-0.0347901100412353,-0.0189225602210867,3.31975020372086e-11
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23118.Leg predicted mass (left),48047,-0.0267041975967837,0.00406400608387456,-0.0346696495211779,-0.0187387456723896,5.10272512705726e-11
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23119.Arm fat percentage (right),48047,0.0273058526249466,0.00454858980651069,0.0183906166041857,0.0362210886457075,1.96286620096994e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23120.Arm fat mass (right),48047,0.0124714038780653,0.00443509725703592,0.00377861325427494,0.0211641945018557,0.00492772333350526
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23121.Arm fat-free mass (right),48046,-0.0190356266011598,0.00363610476601651,-0.0261623919425521,-0.0119088612597674,1.66209655605101e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23122.Arm predicted mass (right),48045,-0.0195148159781095,0.00363812471427641,-0.0266455404180913,-0.0123840915381277,8.21566862863147e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23123.Arm fat percentage (left),48041,0.0294757409949266,0.00465216522558632,0.0203574971527774,0.0385939848370758,2.40087426469254e-10
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23124.Arm fat mass (left),48041,0.0158109810069757,0.00441784829012808,0.00715199835832466,0.0244699636556267,0.000345735187286384
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23125.Arm fat-free mass (left),48037,-0.0194033442406843,0.00369130527515742,-0.0266383025799929,-0.0121683859013758,1.48069343410391e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23126.Arm predicted mass (left),48036,-0.0188321739345216,0.00371233903891396,-0.026108358450793,-0.0115559894182503,3.94779843871632e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23127.Trunk fat percentage,48034,0.0194968856048902,0.00294644292944211,0.0137218574631837,0.0252719137465968,3.73993979909881e-11
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23128.Trunk fat mass,48030,0.0114236119707873,0.00321313381585611,0.0051258696917093,0.0177213542498652,0.000378287913973782
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23129.Trunk fat-free mass,48025,-0.0225760887104213,0.00330195911478774,-0.0290479285754053,-0.0161042488454373,8.26907659300287e-12
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23130.Trunk predicted mass,48023,-0.022005852381923,0.00329743720183558,-0.0284688292975208,-0.0155428754663253,2.5496509155631e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23400.Total Cholesterol,37445,0.0574716403170506,0.00245171186540475,0.0526662850608573,0.0622769955732439,3.69207649687605e-119
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37445,0.0342877253463226,0.00240569835028457,0.0295725565797649,0.0390028941128804,9.2140697600058e-46
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37445,0.0292763813722161,0.00242102623159339,0.0245311699582931,0.0340215927861392,1.71833718188751e-33
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23403.VLDL Cholesterol,37445,0.00654446332493213,0.00239351994147572,0.00185316423963972,0.0112357624102245,0.00626050435046173
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23404.Clinical LDL Cholesterol,37445,0.038632308567137,0.0023982632340865,0.0339317126283275,0.0433329045059466,7.6356147477278e-58
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23405.LDL Cholesterol,37445,0.0371905765435465,0.00238025848882517,0.0325252699054491,0.0418558831816438,1.47638921052289e-54
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23406.HDL Cholesterol,37445,0.0902788392846802,0.00263185507035662,0.0851204033467812,0.0954372752225791,2.20135441449162e-247
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23407.Total Triglycerides,37445,-0.0136494232901027,0.00245549857250935,-0.0184622004922211,-0.00883664608798438,2.76884021296596e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23408.Triglycerides in VLDL,37445,-0.0167890497274915,0.00249330075685617,-0.0216759192109296,-0.0119021802440534,1.72091608513926e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23409.Triglycerides in LDL,37445,-0.00187015494017615,0.00235010577957975,-0.00647636226815245,0.00273605238780016,0.426176849731129
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23410.Triglycerides in HDL,37445,-0.00197036452238351,0.00231997585753458,-0.0065175172031513,0.00257678815838427,0.395727182389539
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37445,0.0608962929270259,0.00241992425876213,0.0561532413798522,0.0656393444741997,1.28715650443076e-136
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23412.Phospholipids in VLDL,37445,-0.0050235562816251,0.0024194952929866,-0.00976576705587884,-0.000281345507371364,0.037886568152324
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23413.Phospholipids in LDL,37445,0.0338590396834602,0.00238532616885578,0.0291838003925029,0.0385342789744175,2.08519950177258e-45
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23414.Phospholipids in HDL,37445,0.0747136150179881,0.00249012564355601,0.0698329687566183,0.0795942612793579,1.44080129170655e-191
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23415.Total Esterified Cholesterol,37445,0.061132131444413,0.00245518951321107,0.0563199599985194,0.0659443028903067,7.44680798203328e-134
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37445,0.0112749719367218,0.0023928400073378,0.00658500552233975,0.0159649383511039,2.47775007460607e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37445,0.0347270958047275,0.00237372322405927,0.0300745982855714,0.0393795933238837,4.20868637907725e-48
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37445,0.0910025135536645,0.00262458057954952,0.0858583356177474,0.0961466914895815,1.70479277130185e-252
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23419.Total Free Cholesterol,37445,0.0473149274406114,0.00244050021337538,0.0425315470223956,0.0520983078588271,1.2840798459073e-82
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23420.Free Cholesterol in VLDL,37445,0.000262950144241255,0.0024068643306584,-0.00445450394384921,0.00498040423233172,0.913005745740395
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23421.Free Cholesterol in LDL,37445,0.0427069202382115,0.00240307812241019,0.0379968871182876,0.0474169533581355,7.2134707839272e-70
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23422.Free Cholesterol in HDL,37445,0.0813867270909561,0.00262759752449082,0.0762366359429541,0.086536818238958,1.33728212330225e-203
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37445,0.0422296629653248,0.00238373836260592,0.0375575357746172,0.0469017901560324,1.91182329271639e-69
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23424.Total Lipids in VLDL,37445,-0.00829984483795113,0.0024416591044098,-0.0130854966825943,-0.00351419299330791,0.000677615772858106
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23425.Total Lipids in LDL,37445,0.0347734702897852,0.00238014631475355,0.0301083835128682,0.0394385570667021,5.61980989687865e-48
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23426.Total Lipids in HDL,37445,0.0803397650758192,0.00253774166729399,0.0753657914079229,0.0853137387437154,2.74890726290106e-212
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37445,0.0814312272468039,0.00238439180531394,0.0767578193083886,0.0861046351852193,2.54122966222061e-245
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23428.Concentration of VLDL Particles,37445,0.0016479986202249,0.00238956506459214,-0.00303554890637568,0.00633154614682549,0.490416863698495
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23429.Concentration of LDL Particles,37445,0.0213328704123411,0.00239443808150354,0.0166397717725942,0.0260259690520881,5.77881166290538e-19
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23430.Concentration of HDL Particles,37445,0.0813521654474933,0.00238299210660261,0.0766815009185522,0.0860228299764344,3.84013994549145e-245
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37445,-0.027553266774977,0.00260900694934353,-0.0326669203956903,-0.0224396131542636,5.70714780435539e-26
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23432.Average Diameter for LDL Particles,37445,0.0258236030515823,0.00238833220899316,0.0211424719219557,0.0305047341812089,3.87788312520181e-27
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23433.Average Diameter for HDL Particles,37445,0.0478487489915144,0.00274936384358611,0.0424599958580856,0.0532375021249432,4.13663208704693e-67
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23434.Phosphoglycerides,37433,0.0621555556585652,0.00238918084182682,0.0574727612085846,0.0668383501085458,1.19558738130607e-145
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37433,-0.0506203837682606,0.00259916281116788,-0.0557147428781496,-0.0455260246583715,2.41535957574747e-83
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23436.Total Cholines,37433,0.0667093821152486,0.00242388779097177,0.0619585620449439,0.0714602021855532,2.64638806366735e-162
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23437.Phosphatidylcholines,37433,0.0650332417836797,0.00241935279301626,0.0602913103093679,0.0697751732579916,4.12639328181011e-155
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23438.Sphingomyelins,37432,0.0684747094007267,0.00250192159114703,0.0635709430820785,0.0733784757193748,1.41497657080086e-160
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23439.Apolipoprotein B,37445,0.0214760327494916,0.002402969077232,0.0167662133581169,0.0261858521408663,4.49617962892498e-19
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23440.Apolipoprotein A1,37445,0.0796572146996688,0.00246338987610072,0.0748289705425114,0.0844854588568262,4.60867685497184e-221
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37445,-0.0227091411547561,0.00239659056803453,-0.0274064586681038,-0.0180118236414084,3.08449442034539e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23442.Total Fatty Acids,37433,0.0263544682702138,0.00233876538137282,0.0217704881227231,0.0309384484177045,2.53257742960053e-29
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23443.Degree of Unsaturation,37433,0.0509009944132674,0.00255938074671014,0.0458846081497156,0.0559173806768193,8.85610879010596e-87
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23444.Omega-3 Fatty Acids,37433,0.0361465406453445,0.00236698598048074,0.0315072481236022,0.0407858331670867,3.23387665404678e-52
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23445.Omega-6 Fatty Acids,37433,0.0424560814036446,0.00235938591126485,0.0378316850175654,0.0470804777897237,1.45578888673875e-71
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37433,0.0452967316837211,0.00235786020187117,0.0406753256880536,0.0499181376793886,3.57062389512705e-81
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37433,0.00681702918429346,0.00238750423209725,0.00213752088938286,0.0114965374792041,0.00430620515506697
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23448.Saturated Fatty Acids,37433,0.0255210136798595,0.00234926466370019,0.0209164549390071,0.0301255724207118,2.23195584650259e-27
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23449.Linoleic Acid,37433,0.0318017833735903,0.00238897431682,0.0271193937126231,0.0364841730345575,3.5252313115131e-40
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23450.Docosahexaenoic Acid,37433,0.0556388108390122,0.00244901011892262,0.0508387510059238,0.0604388706721005,3.55767431287264e-112
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37433,0.0294004274171657,0.00239902769820902,0.024698333128676,0.0341025217056554,2.39469020257513e-34
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37433,0.0077602811157352,0.00245505924607249,0.00294836499343313,0.0125721972380373,0.00157609653075406
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37433,0.0216359101437483,0.00254502058569938,0.0166476697957775,0.0266241504917191,2.06938168872095e-17
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37433,-0.0395037084258299,0.00259102648353238,-0.0445821203335533,-0.0344252965181064,4.69673409096928e-52
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37433,0.00740103352841254,0.00234761224789869,0.00279971352253111,0.012002353534294,0.00162187233142571
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37433,0.00680282253347583,0.00251422988474325,0.00187493195937906,0.0117307131075726,0.00682399419395497
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37433,0.0385119606225004,0.00249920439795432,0.03361352000251,0.0434104012424909,3.96729733237391e-53
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37433,0.0332843439073909,0.00259346131928856,0.0282011597215854,0.0383675280931965,1.74786001700875e-37
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37431,-0.0234664279655706,0.00238465124363878,-0.0281403444031026,-0.0187925115280386,8.96853006815733e-23
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23460.Alanine,37441,0.000763929044691802,0.0023375484520157,-0.00381766592125897,0.00534552401064258,0.743818303106854
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23461.Glutamine,37400,-0.00983718792937036,0.00230329147607731,-0.0143516392224819,-0.00532273663625883,1.95990703848544e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23462.Glycine,37431,-0.0152299076365889,0.00241059459483806,-0.0199546730424715,-0.0105051422307063,2.7341145352613e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23463.Histidine,37430,0.00392790762831546,0.00229492242596424,-0.000570140326574454,0.00842595558320537,0.0869998161636448
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37433,-0.00872065607318129,0.00245339361354817,-0.0135293075557357,-0.00391200459062689,0.000379945155647678
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23465.Isoleucine,37443,-0.01246821788878,0.00238858766468977,-0.0171498497115719,-0.00778658606598802,1.81646870978522e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23466.Leucine,37444,-0.00814037754836475,0.00246280293588561,-0.0129674713027005,-0.00331328379402896,0.000951102280706086
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23467.Valine,37433,-0.00710032423927575,0.00244671392620052,-0.0118958835346288,-0.00230476494392272,0.00371404018376249
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23468.Phenylalanine,37441,-0.0128700968885902,0.00231206696203766,-0.017401748134184,-0.00833844564299636,2.6484750931221e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23469.Tyrosine,37430,-0.00786482348221047,0.00237856452615505,-0.0125268099534744,-0.00320283701094658,0.000947004665153127
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23470.Glucose,37424,0.00298838562373032,0.00237725782612941,-0.00167103971548333,0.00764781096294397,0.208749000951522
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23471.Lactate,37421,0.000149304779010638,0.00233625145903457,-0.00442974808069712,0.00472835763871839,0.949044553413726
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23472.Pyruvate,37397,-0.000133397246411869,0.00230200269544657,-0.00464532252948714,0.00437852803666341,0.953790629349069
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23473.Citrate,37444,-0.00351203583851445,0.00236011936541335,-0.00813786979472461,0.00111379811769571,0.136754192566692
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23474.3-Hydroxybutyrate,37232,0.00401161266662393,0.00230274078625122,-0.000501759274428461,0.00852498460767632,0.0815133356802265
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23475.Acetate,37435,0.00236840424243857,0.00230882659632478,-0.00215689588635799,0.00689370437123513,0.305002118672978
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23476.Acetoacetate,37445,0.00538713700392917,0.00228972094595235,0.000899283949862562,0.00987499005799579,0.0186494261996053
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23477.Acetone,37445,0.00897489773300445,0.00229889142021265,0.00446907054938766,0.0134807249166212,9.50685884611228e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23478.Creatinine,37096,-0.0118852819031967,0.00292127209770328,-0.0176109752146952,-0.00615958859169831,4.75851622112274e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23479.Albumin,37444,0.0302209068662913,0.0023438649350325,0.0256269315936276,0.034814882138955,8.14692780997219e-38
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23480.Glycoprotein Acetyls,37445,-0.0069325906820835,0.00247331863932728,-0.011780295215165,-0.00208488614900204,0.00507091294147021
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37445,-0.0231892000351881,0.00247730340940378,-0.0280447147176195,-0.0183336853527566,9.15005633154276e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37445,-0.0224294713785182,0.00248931081676822,-0.0273085205793839,-0.0175504221776525,2.3254071199796e-19
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37445,-0.0249035946621732,0.00249107588426759,-0.0297861033953377,-0.0200210859290087,1.89065396789447e-23
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37445,-0.0199052472994086,0.00247456811221681,-0.0247554007993536,-0.0150550937994637,9.4171132644603e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37445,-0.0195929551766912,0.00248049486014345,-0.0244547251025724,-0.01473118525081,3.03114719071084e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37445,-0.0193611296019721,0.0024567692095516,-0.0241763972526932,-0.0145458619512509,3.50138791264236e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37445,-0.0220016753553188,0.00248699946990186,-0.0268761943163264,-0.0171271563943111,1.01169123422203e-18
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37445,-0.0220228604456507,0.00251749183068203,-0.0269571444337874,-0.0170885764575139,2.42592836769214e-18
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37445,-0.0215469811403465,0.00252063556169697,-0.0264874268412726,-0.0166065354394204,1.38211419279748e-17
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37445,-0.0215854059895398,0.00250549231341964,-0.0264961709238423,-0.0166746410552373,7.74262138042709e-18
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37445,-0.0150920280924094,0.00247150250666431,-0.0199361730054714,-0.0102478831793474,1.04669443698954e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37445,-0.0103156716988807,0.00245022851704487,-0.0151181195922886,-0.00551322380547275,2.56917074097415e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37445,-0.019189160765688,0.00248709385778284,-0.0240638647269423,-0.0143144568044336,1.28889324540265e-14
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37445,-0.0231757010421538,0.00254344603344859,-0.0281608552677131,-0.0181905468165946,9.21072884169244e-20
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37445,-0.0181660787587817,0.00249324842795892,-0.0230528456775812,-0.0132793118399823,3.3662401411955e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23496.Total Lipids in Large VLDL,37445,-0.0166383173537106,0.0024952672366822,-0.0215290411376077,-0.0117475935698134,2.6942578902609e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23497.Phospholipids in Large VLDL,37445,-0.020829613105206,0.00250759711880376,-0.0257445034580614,-0.0159147227523506,1.07737579042039e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23498.Cholesterol in Large VLDL,37445,-0.0128379172513885,0.00245375265459092,-0.0176472724543867,-0.00802856204839028,1.70223415079378e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37445,-0.00761942170270729,0.00241481262226097,-0.0123524544423388,-0.00288638896307578,0.00160691331336833
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37445,-0.0177018339033526,0.00249702983376198,-0.0225960123775261,-0.0128076554291791,1.41594770262098e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23501.Triglycerides in Large VLDL,37445,-0.0160335946967934,0.00250895838438553,-0.020951153130189,-0.0111160362633977,1.70697881644997e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37445,0.00947577044330283,0.00238825092178939,0.00479479863659562,0.01415674225001,7.29542925037485e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37445,0.00502187503337172,0.002398585473214,0.000320647505872278,0.00972310256087117,0.0363068154758322
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37445,0.0108737764453989,0.00238823132361219,0.00619284305111898,0.0155547098396788,5.33287982536001e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37445,0.0249641603685928,0.00240572506767929,0.0202489392359414,0.0296793815012442,3.91770465166298e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37445,0.0309909054283285,0.00242926988122086,0.0262295364611356,0.0357522743955214,4.63187378078229e-37
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37445,0.0157986761606945,0.00238546440547683,0.0111231659259599,0.020474186395429,3.65485030976307e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37445,-0.0088099604509599,0.0024585095940537,-0.0136286392553051,-0.00399128164661465,0.000340264941528022
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37445,-0.00598892601904492,0.00239927188611542,-0.0106914989158311,-0.00128635312225869,0.0125669520754254
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23510.Total Lipids in Small VLDL,37445,-0.00203782295173001,0.0023943007405377,-0.00673065240318391,0.00265500649972389,0.394721014254223
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23511.Phospholipids in Small VLDL,37445,0.0084969744107908,0.00237673124308238,0.00383858117434934,0.0131553676472323,0.000351352441236535
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23512.Cholesterol in Small VLDL,37445,0.00809745465902948,0.00238171375920004,0.00342929569099741,0.0127656136270615,0.000676182898443903
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37445,0.00295916529242855,0.00238671114574934,-0.00171878855324015,0.00763711913809725,0.215052067218886
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37445,0.0168801929260749,0.00237954437574129,0.012216285949622,0.0215440999025278,1.36863057694809e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23515.Triglycerides in Small VLDL,37445,-0.015392952496311,0.00242220209276553,-0.0201404685981315,-0.0106454363944906,2.15162071920822e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37445,0.0146409813105982,0.00239736648852258,0.00994214299309389,0.0193398196281024,1.04218106642412e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37445,0.0151757280728754,0.0023892528693056,0.0104927924490364,0.0198586636967143,2.19785739035988e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37445,0.00788302688239436,0.00237650487872221,0.00322507732009882,0.0125409764446899,0.000912064179849417
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37445,0.0300901521355357,0.0024688871365281,0.0252511333479406,0.0349291709231308,5.43622852288981e-34
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37445,0.0351628797622349,0.0024975100693618,0.0302677600262858,0.0400579994981841,1.05132357761014e-44
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37445,0.0177868855561138,0.00240472559005901,0.0130736233995981,0.0225001477126294,1.47857543965493e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37445,-0.0102215332311048,0.002356609550672,-0.0148404879504219,-0.00560257851178769,1.45224953310699e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23523.Concentration of IDL Particles,37445,0.0307726331808666,0.00245279956876004,0.025965146026097,0.0355801203356363,6.61744333660667e-36
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23524.Total Lipids in IDL,37445,0.0483094372475562,0.00249291308548891,0.0434233275999979,0.0531955468951145,1.51315431627272e-82
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23525.Phospholipids in IDL,37445,0.0437387468078164,0.00249692225382475,0.0388447791903199,0.0486327144253129,5.91814858861839e-68
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23526.Cholesterol in IDL,37445,0.0526192921160321,0.0025028612689724,0.0477136840288462,0.0575249002032181,1.36673853377342e-96
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37445,0.0529482296898554,0.00249950257662067,0.0480492046396789,0.0578472547400319,5.17551327717846e-98
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23528.Free Cholesterol in IDL,37445,0.0500659089674226,0.00250287478119692,0.0451602743962766,0.0549715435385685,9.39681509673016e-88
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23529.Triglycerides in IDL,37445,-0.00177678094299755,0.00232748987033041,-0.00633866108884516,0.00278509920285005,0.445244495316162
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23530.Concentration of Large LDL Particles,37445,0.0233002497728806,0.00239846562077854,0.0185992571561547,0.0280012423896065,3.08488619582218e-22
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23531.Total Lipids in Large LDL,37445,0.0411142757204771,0.00239314473173853,0.0364237120462696,0.0458048393946846,1.83971949000663e-65
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23532.Phospholipids in Large LDL,37445,0.0413969241130813,0.00239980695577084,0.0366933024797704,0.0461005457463921,5.62643665215662e-66
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23533.Cholesterol in Large LDL,37445,0.0429851875746075,0.0023950048677639,0.0382909780337903,0.0476793971154247,3.30729226614633e-71
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37445,0.0409431620010819,0.00238365639586064,0.036271195465195,0.0456151285369687,1.94831792277215e-65
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37445,0.0475937935570939,0.00242983170647049,0.0428313234124117,0.052356263701776,2.87451374278611e-84
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23536.Triglycerides in Large LDL,37445,0.00109657263031137,0.00233684423022899,-0.00348364206093745,0.0056767873215602,0.63889588862336
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37445,0.0193711600484048,0.00238155635905778,0.0147033095846515,0.024039010512158,4.51819164808433e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23538.Total Lipids in Medium LDL,37445,0.0253883967083183,0.00236824418438691,0.02074663810692,0.0300301553097167,1.04471519594569e-26
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23539.Phospholipids in Medium LDL,37445,0.0249608056067522,0.0023646719507717,0.0203260485832397,0.0295955626302647,6.02367655900742e-26
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23540.Cholesterol in Medium LDL,37445,0.0273715638770345,0.00236709809591829,0.0227320516090346,0.0320110761450343,8.80639911003075e-31
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37445,0.0238188122827542,0.0023729508845488,0.0191678285490386,0.0284697960164699,1.25879926559742e-23
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37445,0.0354358212047012,0.00236084829578978,0.0308085585449532,0.0400630838644492,1.60905497897747e-50
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23543.Triglycerides in Medium LDL,37445,-0.00443780453763654,0.00236861596134179,-0.00908029182186645,0.000204682746593364,0.0610090283011986
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23544.Concentration of Small LDL Particles,37445,0.0124797545642227,0.00239678571944434,0.00778205455411181,0.0171774545743336,1.94854619904931e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23545.Total Lipids in Small LDL,37445,0.0197650554179537,0.00239006814181392,0.0150805218599985,0.024449588975909,1.46737052743719e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23546.Phospholipids in Small LDL,37445,0.0173944630699951,0.00239772375112243,0.0126949245177951,0.022094001622195,4.24757916548874e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23547.Cholesterol in Small LDL,37445,0.0235477195829216,0.00238334365205617,0.0188763660248915,0.0282190731409517,6.06694589417673e-23
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37445,0.0205949797985326,0.00238668599482288,0.0159170752486798,0.0252728843483855,6.86329902421913e-18
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37445,0.0290544323101383,0.00237231191059081,0.0244047009653803,0.0337041636548962,2.6338921644926e-34
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23550.Triglycerides in Small LDL,37445,-0.0116403088110235,0.00239657615834664,-0.016337598081383,-0.00694301954066413,1.20470745367672e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37445,0.0398122953329494,0.00278588882033445,0.0343519532450939,0.0452726374208049,5.38715780684012e-46
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37445,0.0373637536031445,0.00279472109963263,0.0318861002478645,0.0428414069584244,1.64542303714311e-40
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37445,0.0330311018558327,0.00276401311361136,0.0276136361531545,0.038448567558511,9.42717687691712e-33
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37445,0.0446502734088476,0.00283436438975388,0.03909491920493,0.0502056276127652,2.01907908691093e-55
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37445,0.0520793047350347,0.00286072291480537,0.0464722878220162,0.0576863216480532,3.48787908409099e-73
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37445,0.018278320470159,0.00268406617663284,0.0130175507639586,0.0235390901763593,1.01746223904134e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37445,-0.00269738543737449,0.00228011162009259,-0.00716640421275597,0.00177163333800699,0.236827522346204
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23558.Concentration of Large HDL Particles,37445,0.0724993975639479,0.00280420164793646,0.0670031623339924,0.0779956327939034,6.47388250290916e-144
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23559.Total Lipids in Large HDL,37445,0.0699010860015584,0.00276434619823544,0.064482967453017,0.0753192045500999,6.75562064463894e-138
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23560.Phospholipids in Large HDL,37445,0.0674450412773693,0.00270509892725598,0.0621430473799476,0.072747035174791,3.35496687588899e-134
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23561.Cholesterol in Large HDL,37445,0.0735517339638076,0.00282980745835468,0.0680053113454324,0.0790981565821827,2.13442232074699e-145
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37445,0.0751321374587141,0.0028331003345301,0.0695792608030351,0.0806850141143931,3.93768631528717e-151
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37445,0.0663520080376246,0.00280077691510218,0.0608624852840244,0.0718415307912249,1.29774223855831e-121
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23564.Triglycerides in Large HDL,37445,0.0100636648659181,0.00229361187773705,0.00556818558555345,0.0145591441462827,1.15422810379708e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37445,0.077854375484124,0.00243614270938947,0.0730795357737206,0.0826292151945273,3.77937543557174e-216
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23566.Total Lipids in Medium HDL,37445,0.0738399185540462,0.0024027055569209,0.0691306156624812,0.0785492214456111,1.43730103763924e-200
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23567.Phospholipids in Medium HDL,37445,0.0684981639371234,0.00237099553478062,0.0638510126889533,0.0731453151852934,3.6682164903908e-178
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23568.Cholesterol in Medium HDL,37445,0.0826387525789671,0.00246569565795294,0.0778059890893793,0.0874715160685549,1.08834556524628e-236
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37445,0.0824678232208426,0.00246061285725912,0.0776450220206148,0.0872906244210705,1.09628587424086e-236
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37445,0.0802426514628554,0.00247860758431091,0.075384580597606,0.0851007223281048,1.48507958862237e-221
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23571.Triglycerides in Medium HDL,37445,0.00202991896014172,0.00232810611116069,-0.00253316901773324,0.00659300693801668,0.383268209273063
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23572.Concentration of Small HDL Particles,37445,0.0561250993430812,0.00225917954935355,0.0516971074263482,0.0605530912598141,2.82882099890827e-133
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23573.Total Lipids in Small HDL,37445,0.0529933930747451,0.00227702920017705,0.0485304158423981,0.0574563703070921,1.63110284694887e-117
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23574.Phospholipids in Small HDL,37445,0.0534647999529783,0.00227969938238114,0.0489965891635112,0.0579330107424453,2.87158065744556e-119
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23575.Cholesterol in Small HDL,37445,0.0596742965913704,0.00224909512145926,0.0552660701533103,0.0640825230294306,2.82319346817751e-151
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37445,0.0574424932891831,0.00224307705034278,0.0530460622705112,0.0618389243078549,2.66871557536559e-141
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37445,0.0580431162116176,0.00229167600701914,0.05355143123786,0.0625348011853751,2.49563737501462e-138
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23578.Triglycerides in Small HDL,37445,-0.0188335058568783,0.0025016663085241,-0.0237367718215855,-0.0139302398921711,5.4604002371105e-14
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,-0.0116074229879677,0.00234423923206403,-0.0162021318828132,-0.00701271409312222,7.45851665128064e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,0.0140845849782947,0.00233208813986407,0.00951369222416116,0.0186554777324283,1.58858129627518e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,0.0108802707670599,0.00231301891374002,0.0063467536961295,0.0154137878379904,2.57845293464409e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,0.0163014581363219,0.0023669596312644,0.0116622172590437,0.0209406990136001,5.95784275358792e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,-0.00639525906948334,0.00229253637074401,-0.0108886303561416,-0.00190188778282508,0.00528504119538179
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37277,-0.00867651199058846,0.00227193612951767,-0.0131295068044431,-0.00422351717673382,0.000134599921189977
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37277,0.0250353109822645,0.00254366865882389,0.0200497204109696,0.0300209015535593,8.84626200915243e-23
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37277,0.0261454678371283,0.00253208964004328,0.0211825721426435,0.0311083635316132,6.68699875378158e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37277,0.0140705748048749,0.00243216945910054,0.00930352266503788,0.018837626944712,7.40443132802764e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37277,-0.0182380081405704,0.00246951015478995,-0.0230782480439587,-0.0133977682371821,1.6111135741196e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37441,-0.0312113793019154,0.00245820236029684,-0.0360294559280972,-0.0263933026757336,9.95592589422779e-37
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37441,0.0118359557076618,0.00237255821917226,0.00718574159808413,0.0164861698172394,6.15419938798481e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37441,0.0203131661190828,0.00247321278736663,0.0154656690558442,0.0251606631823214,2.3456242256709e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37441,-0.00958967889057748,0.00231355248243482,-0.0141242417561497,-0.00505511602500524,3.41872979544196e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37441,0.00336778374834419,0.00227840268084608,-0.00109788550611413,0.0078334530028025,0.139395190128604
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37445,0.0309090251435688,0.00248896051087023,0.0260306625422631,0.0357873877448744,3.22269736881209e-35
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37445,0.0378664943509588,0.00259262875380632,0.0327849419934984,0.0429480467084191,5.98518075751127e-48
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37445,0.0377518843779483,0.00260192947760714,0.0326521026018384,0.0428516661540583,2.39373943636016e-47
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37445,0.0362882014424573,0.00254165295307678,0.0313065616544268,0.0412698412304878,6.50149105524932e-46
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37445,-0.0369126678497831,0.00257608167080632,-0.0419617879245635,-0.0318635477750027,3.13140786200848e-46
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37445,0.0410666083943556,0.00246997157170819,0.0362254641138075,0.0459077526749036,1.81688301100189e-61
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37445,0.0246948706424948,0.00239663153807904,0.0199974728278599,0.0293922684571298,8.34134721184882e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37445,0.0102151137531377,0.00233420952352032,0.00564006308703786,0.0147901644192375,1.21632557699625e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37445,0.0426602149380249,0.00248718430636913,0.0377853336975414,0.0475350961785084,2.94994979885566e-65
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37445,-0.0299831764998133,0.00241966427923319,-0.0347257184871103,-0.0252406345125162,4.49674071342835e-35
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37445,-0.0583531652329185,0.00238037950888248,-0.0630187090703282,-0.0536876213955088,6.77666309045419e-130
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37445,0.04736654582112,0.00253233491269896,0.04240316939223,0.05232992225001,4.20482622312275e-77
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37445,0.0505830148274258,0.00255725177234448,0.0455708013536306,0.055595228301221,7.0922934503701e-86
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37445,0.0161579842942068,0.00232646808847486,0.0115981068407961,0.0207178617476176,3.94873722261805e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37445,-0.0374241406883149,0.00251810852754972,-0.0423596334023123,-0.0324886479743174,1.42511822158531e-49
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37445,-0.0369503231394149,0.00232729026005235,-0.0415118120491175,-0.0323888342297123,2.93094666344109e-56
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37445,0.0497754992147073,0.00242446955830714,0.0450235388804253,0.0545274595489893,2.8757082202748e-92
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37445,0.047045555027512,0.00240068230745829,0.0423402177048937,0.0517508923501302,2.39911922910127e-84
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37445,0.0224877995572001,0.0023936229212363,0.0177962986315769,0.0271793004828232,6.62858507137418e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37445,-0.045073380785759,0.00245476003272785,-0.0498847104499056,-0.0402620511216124,2.11227064175214e-74
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37445,-0.00780726219019022,0.00234637469315808,-0.0124061565887801,-0.00320836779160039,0.000879019128868896
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37445,0.0478373242561037,0.00243086783136117,0.0430728233066358,0.0526018252055715,4.95650126988886e-85
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37445,0.0238332378017317,0.00230622787440627,0.0193130311678954,0.028353444435568,6.09881373295639e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37445,0.0398825995304331,0.00258051059408624,0.0348247987660241,0.0449404002948422,1.97846925611236e-53
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37445,-0.0405322835443836,0.00238222361468207,-0.0452014418291605,-0.0358631252596068,2.96595250105886e-64
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37445,-0.0106082585989815,0.00231829812336558,-0.015152122920778,-0.00606439427718495,4.78417422191137e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37445,0.0413132059378746,0.0023878743017945,0.0366329723063574,0.0459934395693918,2.36333592555534e-66
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37445,0.00283952478200814,0.00240080984423189,-0.00186606251268637,0.00754511207670264,0.236934399967745
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37445,0.0303934735801756,0.00250986202537085,0.0254741440104487,0.0353128031499025,1.39882024340881e-33
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37445,-0.0341759111195282,0.00233171781515598,-0.0387460780372339,-0.0296057442018225,2.83971670675328e-48
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37445,-0.0150799872757824,0.00237179523289623,-0.0197287059322591,-0.0104312686193058,2.1086952553017e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37445,0.041398422910102,0.00230912344219001,0.0368725409634096,0.0459243048567944,4.67180758255571e-71
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37445,0.0147553159304229,0.00237672195798729,0.0100969408927678,0.019413690968078,5.51324398227691e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37445,0.0237045749426708,0.00239329058691521,0.019013725392317,0.0283954244930246,4.75906931790275e-23
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37445,-0.0307852819814221,0.00239924835133032,-0.0354878087500295,-0.0260827552128147,1.80893287843556e-37
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37440,0.0165696968768989,0.00262696424546582,0.0114208469557859,0.021718546798012,2.92283596419195e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37440,0.00369866511866037,0.00241683646173857,-0.00103833434634724,0.00843566458366797,0.125947326406991
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37440,0.0428970042188495,0.00227886576089291,0.0384304273274994,0.0473635811101996,4.73158151371258e-78
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37440,-0.0568133981460643,0.002737752433759,-0.062179392916232,-0.0514474033758967,3.39384693606063e-94
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37440,-0.0299797658904777,0.00257700505760895,-0.0350306958033912,-0.0249288359775642,3.90849650463048e-31
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37445,-0.020396707437773,0.00259745273161539,-0.0254877147917392,-0.0153057000838068,4.37993233774446e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37445,0.0391923887467782,0.00263622561055824,0.0340253865500841,0.0443593909434724,1.32706000914588e-49
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37445,0.036962224947738,0.00254483876331367,0.0319743409716432,0.0419501089238328,1.92428957683336e-47
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37445,0.0199500747150237,0.00260333009713473,0.0148475477246397,0.0250526017054078,1.93482066669858e-14
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37445,-0.0445561824836882,0.00248439970972971,-0.0494256059147584,-0.039686759052618,4.19053656638988e-71
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37445,-0.0581361743311316,0.00257533373172333,-0.0631838284453093,-0.0530885202169538,8.37767601954941e-111
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37445,0.0526043267312418,0.00252992210464459,0.0476456794061384,0.0575629740563452,1.48126388618242e-94
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37445,0.0378255863038639,0.00243266287852008,0.0330575670619646,0.0425936055457633,4.71720588717767e-54
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37445,0.0793016341372295,0.00268886128628773,0.0740314660161056,0.0845718022583535,2.33033948986358e-185
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37445,-0.044086831557846,0.0024666348582075,-0.0489214358799327,-0.0392522272357593,1.22450031360344e-70
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37445,0.00996144751656955,0.00231000762034068,0.00543383258070181,0.0144890624524373,1.62704154508546e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37445,0.0224236875441938,0.00230732762307787,0.0179013254029612,0.0269460496854265,2.97214021290931e-22
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37445,0.0174570578909208,0.00226581021085672,0.0130160698776416,0.0218980459041999,1.40373922594052e-14
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37445,0.0200075254217712,0.00253261155040811,0.0150436067829713,0.0249714440605711,3.00345789117071e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37445,-0.0519089826624871,0.00251538645600456,-0.056839140116256,-0.0469788252087181,3.44104559831568e-93
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48073,-0.000887998127737394,0.00197634356205549,-0.00476163150936616,0.00298563525389137,0.653209438264012
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48073,-0.0015564091867909,0.0019355504709932,-0.00535008810993757,0.00223726973635577,0.421337257671418
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46298,-0.00275212539014116,0.00185876866643878,-0.00639531197636116,0.000891061196078837,0.138722573879635
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46298,-0.0030508512001226,0.00201283234804296,-0.00699600260228681,0.000894300202041599,0.129609162203125
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46298,-3.20413551851748e-05,0.00199823141802698,-0.00394857493451806,0.00388449222414771,0.987206725908666
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46298,0.00016617182327213,0.00184486750036514,-0.00344976847744355,0.00378211212398781,0.928230408154682
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24009.Traffic intensity on the nearest road,48073,0.0658704209094367,0.0979943417027365,-0.126198488827927,0.2579393306468,0.50147173044257
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24010.Inverse distance to the nearest road,48073,0.000798471058817681,0.00173081106517554,-0.00259391862892637,0.00419086074656174,0.644567670505235
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24011.Traffic intensity on the nearest major road,48073,-0.000891251355491342,0.00174719523620218,-0.00431575401844762,0.00253325130746493,0.609983221965125
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24012.Inverse distance to the nearest major road,48073,0.000192403958365943,0.00177380822298867,-0.00328426015869184,0.00366906807542373,0.913624231340761
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24013.Total traffic load on major roads,48073,0.0368805233124382,0.0673620574392428,-0.0951491092684777,0.168910155893354,0.58404238825871
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24015.Sum of road length of major roads within 100m,48073,0.0375554985204195,0.065662203639205,-0.0911424206124223,0.166253417653261,0.567361146857875
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48073,-0.000715642136979826,0.00198421137280635,-0.00460469642768027,0.00317341215372062,0.71835057324306
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48073,-0.000831795942420404,0.00198399855134184,-0.0047204331030504,0.00305684121820959,0.675035477447275
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48073,-0.00110848097177307,0.00196360053090901,-0.00495713801235474,0.00274017606880859,0.572409264186684
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48026,-0.00333162067111323,0.00189925639082657,-0.00705416319713331,0.00039092185490684,0.0794138677284988
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24020.Average daytime sound level of noise pollution,48073,0.000995533480184574,0.00173652428255648,-0.00240805411362612,0.00439912107399527,0.566453104555693
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24021.Average evening sound level of noise pollution,48073,0.000997605368776973,0.00173637957615374,-0.00240569860048437,0.00440090933803831,0.565613292227536
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24022.Average night-time sound level of noise pollution,48073,0.000987079362347223,0.0017365665734592,-0.00241659112163281,0.00439074984632726,0.569762828402665
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48073,0.000992383768125333,0.0017364993144853,-0.00241115488826584,0.00439592242451651,0.567676051508598
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48073,0.000992900221768313,0.00173657561699599,-0.00241078798754383,0.00439658843108045,0.567491546657532
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2405.Number of children fathered,34677,-0.0422555599271953,0.0729622485359633,-0.185261567057683,0.100750447203293,0.562504891450603
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45175,0.00123009199003164,0.00205862023725001,-0.00280480367497838,0.00526498765504166,0.55015842718577
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45175,-0.0027410613723899,0.00187874348377553,-0.00642339860058993,0.000941275855810132,0.14458356010706
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24502.Water percentage, buffer 1000m",45175,0.000502513492172817,0.00182858648083093,-0.00308151601025581,0.00408654299460145,0.783465029036934
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45175,0.0028341831863505,0.0019462900257574,-0.000980545264133994,0.006648911636835,0.145352686090043
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45175,-0.00318189222527744,0.00190749636676804,-0.00692058510414279,0.000556800653587914,0.0953108220512119
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24505.Water percentage, buffer 300m",45175,0.00137184466806092,0.00183858692704473,-0.00223178570894675,0.00497547504506859,0.455590611083395
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48164,0.00095265621859853,0.00194825741454203,-0.00286592831390384,0.0047712407511009,0.624861246992492
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48164,0.00141135798217005,0.00183801802494926,-0.00219115734673049,0.00501387331107059,0.442572179154278
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24508.Distance (Euclidean) to coast,48164,0.000245999393594149,0.00175772699569698,-0.00319914551797192,0.00369114430516022,0.888698182893289
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28110,-0.023019055763089,0.115588943457177,-0.249573384939156,0.203535273412978,0.842158200538638
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2704.Years since last cervical smear test,34087,0.127676646760478,0.0685521287946558,-0.00668552567704722,0.262038819198003,0.0625647772466843
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2714.Age when periods started (menarche),37020,-0.0796489856323686,0.0607251339140137,-0.198670248103835,0.0393722768390982,0.189667452112022
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2734.Number of live births,37436,-0.193273453186068,0.0592505354841586,-0.309404502735018,-0.0771424036371167,0.0011091420432807
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2744.Birth weight of first child,34060,0.0793048906294397,0.0670566048402297,-0.0521260548574104,0.21073583611629,0.236973128988195
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2754.Age at first live birth,32284,0.00195054176712854,0.00291875302940871,-0.00377021417051253,0.00767129770476962,0.503973733174577
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2764.Age at last live birth,32260,0.000836257024100319,0.00291690083830758,-0.00488086861898255,0.00655338266718318,0.774353950142247
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2794.Age started oral contraceptive pill,35429,-0.00190690695486742,0.00288596323677564,-0.00756339489894768,0.00374958098921283,0.508784308940125
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2804.Age when last used oral contraceptive pill,34378,0.00627903657106186,0.00257507454163758,0.0012318904694522,0.0113261826726715,0.014769271875879
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2867.Age started smoking in former smokers,28654,0.00249651004262161,0.00378061310789483,-0.00491349164885226,0.00990651173409548,0.509064001583793
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34473,-0.126009797091077,0.0827947129853909,-0.288287434542443,0.036267840360289,0.12805024644567
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34469,-0.150521603238345,0.0910640931450652,-0.329007225802673,0.0279640193259824,0.0983768698045885
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34487,-0.196302724004919,0.0937086324257787,-0.379971643559445,-0.0126338044503926,0.0362106100234798
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34459,-0.147446671334543,0.0914737532051897,-0.326735227616715,0.031841884947629,0.107013176139137
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28739.Difficulty with standing for long periods,34503,-0.254746513488956,0.0853512715634995,-0.422035005753415,-0.087458021224497,0.00284517253568518
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28740.Difficulty with taking care of household responsibilities,34521,-0.378034170929855,0.0940706609657744,-0.562412666422773,-0.193655675436937,5.89427182654252e-05
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28741.Difficulty learning a new task,34440,-0.256990810771136,0.10641097315959,-0.465556318163932,-0.0484253033783407,0.0157486854280411
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28742.Difficulty with joining in community activities,34058,-0.198096781521949,0.103013342370727,-0.400002932568574,0.00380936952467634,0.0545052824824877
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28743.Difficulty with being emotionally affected by health problems,34444,-0.380044332007496,0.0883189062319729,-0.553149388222163,-0.206939275792829,1.69945391207282e-05
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,34517,-0.335799231385067,0.118889431550963,-0.568822517224954,-0.102775945545181,0.0047447352319391
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28520,0.00218199550888997,0.110456266118663,-0.214312286083689,0.218676277101469,0.984240152886264
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2897.Age stopped smoking,28657,-0.00342636207968788,0.00452569014574257,-0.0122967147653433,0.00544399060596755,0.44903215870251
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,33327,0.00645733802347427,0.00548786204408193,-0.00429887158292631,0.0172135476298748,0.239361531506084
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,33327,-0.0176446571554529,0.00588274178244435,-0.0291748310490439,-0.00611448326186199,0.00271221296848571
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,33327,0.00367461746367201,0.0199222709610742,-0.0353730336200335,0.0427222685473775,0.853666187223449
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,33327,0.0356302352603832,0.0197771953731756,-0.00313306767104102,0.0743935381918074,0.071643030611705
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,33327,0.0203822767446387,0.020769801058623,-0.0203265333302624,0.0610910868195398,0.326449227520779
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,33327,-0.0187250837538087,0.0178517793986412,-0.0537145713751454,0.016264403867528,0.294241837184026
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,33327,0.00205659953290281,0.00816811673070086,-0.0139529092592709,0.0180661083250765,0.801213639067072
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,33327,0.000458744319107308,0.014807645965238,-0.0285642417727592,0.0294817304109738,0.975285957114733
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29002.Recent lack of interest or pleasure in doing things,33267,-0.231691008448677,0.0948667957170781,-0.41762992805415,-0.045752088843204,0.0146132219026063
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29003.Recent feelings of depression,33265,-0.234402520048342,0.091733479632576,-0.414200140128191,-0.054604899968493,0.0106265733155916
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",33273,-0.13730661448303,0.0763510686460833,-0.286954709029353,0.0123414800632932,0.0721522047645304
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29005.Recent feelings of tiredness or low energy,33278,-0.322785024314496,0.0772232890653338,-0.47414267088255,-0.171427377746442,2.94285005602823e-05
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29006.Recent poor appetite or overeating,33281,-0.28635305279314,0.100033601193043,-0.482418911131505,-0.0902871944547746,0.00421149056270711
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29007.Recent feelings of inadequacy,33247,-0.211779834431898,0.0980551626348292,-0.403967953196163,-0.0195917156676327,0.0308131666040041
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29008.Recent trouble concentrating on things,33278,-0.126860617344407,0.0986696563941584,-0.320253143876957,0.0665319091881437,0.198575718944536
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29009.Recent changes in speed or amount of moving or speaking,33269,-0.414145992218558,0.171834232008998,-0.750941086956195,-0.0773508974809217,0.0159651010412436
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29010.Recent thoughts of suicide or self-harm,33215,-0.349550581164671,0.185219557792345,-0.712580914437667,0.013479752108325,0.0591612962578596
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#0.Substances taken for depression_None of options listed,31586,0.00261203715419685,0.0108172957821324,-0.0185898625787827,0.0238139368871764,0.809198366381885
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31586,0.00947477912771907,0.0188076483316565,-0.0273882116023276,0.0463377698577658,0.614435502057083
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31586,-0.00860172075439931,0.0107334712158214,-0.0296393243374092,0.0124358828286106,0.422929239916322
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31586,0.0109719254224087,0.0307785375827605,-0.0493540082398018,0.0712978590846192,0.721491048021083
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31586,-0.0241824063641936,0.0184505702441006,-0.0603455240426308,0.0119807113142437,0.190011947081345
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31586,-0.000901773777851263,0.0198645339035419,-0.0398362602287935,0.0380327126730909,0.963792706177822
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31586,-0.0110288236557417,0.023289955064501,-0.0566771355821636,0.0346194882706802,0.635838338726392
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31586,0.0137198968251075,0.0270428870184213,-0.0392841617309983,0.0667239553812134,0.611931833747882
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31586,-0.00926069594303003,0.0214986415634444,-0.0513980334073811,0.0328766415213211,0.666656895584296
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31586,0.0132225161801319,0.0109417626554491,-0.00822333862454828,0.034668370984812,0.226913201258165
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31586,0.0095988372472947,0.016099170864209,-0.0219555376465549,0.0411532121411443,0.551037867730948
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31586,-0.00538317703906572,0.0252554122791054,-0.0548837851061123,0.0441174310279809,0.831216025172769
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31586,-0.0328929617451928,0.0309669391124107,-0.0935881624055178,0.0278022389151322,0.288179873317207
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31586,-0.000860355468029906,0.0198719762685071,-0.0398094289543039,0.0380887180182441,0.965467565711021
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31586,-0.0198749862275404,0.0322663922459919,-0.0831171150296846,0.0433671425746038,0.537935399115579
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31586,-0.01436299762846,0.0302042489810087,-0.0735633256312371,0.0448373303743171,0.634423381037226
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31586,-0.000111922959279692,0.0166784967039073,-0.032801776498938,0.0325779305803786,0.994645917861102
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31586,0.0109471835254482,0.0163323654566439,-0.0210642527695738,0.0429586198204701,0.502702250888379
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31586,-0.00395902862366434,0.0233353395164521,-0.0496962940759105,0.0417782368285818,0.865283494491017
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29058.Recent feelings or nervousness or anxiety,33127,-0.125862629202535,0.0884180400227905,-0.299161987647204,0.0474367292421348,0.154626412094873
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29059.Recent inability to stop or control worrying,33132,-0.209955522891207,0.092370238394078,-0.391001190143599,-0.0289098556388138,0.0230502869427105
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29060.Recent worrying too much about different things,33124,-0.18258233456729,0.0851572227156439,-0.349490491089952,-0.0156741780446278,0.0320539009163459
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29061.Recent trouble relaxing,33131,-0.135776801750793,0.0890808243778694,-0.310375217531417,0.0388216140298307,0.127493409110145
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29062.Recent restlessness,33132,-0.412226246692196,0.121344679577739,-0.650061818664564,-0.174390674719828,0.000683775584946935
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29063.Recent easy annoyance or irritability,33117,-0.0162055854713848,0.0903391819146234,-0.193270382024047,0.160859211081277,0.857638541846207
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29064.Recent feelings of foreboding,33110,-0.121245885868448,0.103000295104407,-0.323126464273087,0.0806346925361898,0.239169467436863
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31586,0.00370279770437979,0.0110495411100053,-0.0179543028712306,0.0253598982799902,0.737552164423511
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31586,-0.00458458987070352,0.0179003803316577,-0.0396693353207526,0.0305001555793456,0.797867393636956
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31586,0.0380717035876228,0.0237116770750316,-0.00840318347943922,0.0845465906546848,0.10840051673065
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31586,0.0140443876772338,0.0261891682470546,-0.0372863820869932,0.0653751574414608,0.591789447267673
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#2.Symptoms of panic attack_Sweating,31586,-0.0130064919707509,0.0166773201094056,-0.0456940393851858,0.0196810554436841,0.435478922628797
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31586,-0.0113959300496006,0.0179746373529382,-0.0466262192613595,0.0238343591621583,0.526099229843326
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31586,0.0121672222385514,0.0179427921067374,-0.0230006502906539,0.0473350947677568,0.497721005007949
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31586,-0.00075192632439354,0.0165192469268942,-0.0331296503011061,0.031625797652319,0.963695447770511
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31586,-0.00353710652849065,0.021888333294469,-0.0464382397856499,0.0393640267286686,0.871626814585807
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29076.Felt loved as a child,33091,0.138332978970889,0.0791549303147528,-0.0168106844460268,0.293476642387804,0.0805625847700001
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29077.Physically abused by family as a child,33095,-0.256886668951158,0.100290566501948,-0.453456179294976,-0.0603171586073404,0.0104401462919735
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29078.Felt hated by family member as a child,33082,-0.309503789350036,0.102534968425701,-0.510472327464411,-0.108535251235661,0.00254707529151171
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29079.Sexually molested as a child,33017,-0.141762353434814,0.140594093963216,-0.417326777602718,0.133802070733089,0.313332579482386
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29080.Someone to take to doctor when needed as a child,33081,0.289917108616793,0.116476398944088,0.0616233666863813,0.518210850547205,0.0128255261024606
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,33079,-0.0749728008354914,0.142385545669848,-0.354048470348394,0.204102868677411,0.598520294320153
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29082.Belittlement by partner or ex-partner as an adult,33032,-0.167667872161111,0.111473091493245,-0.386155131487872,0.0508193871656503,0.13258729504926
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29083.Physical violence by partner or ex-partner as an adult,33086,-0.201480593849258,0.122484852870551,-0.441550905475538,0.0385897177770229,0.100015649590844
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,33054,-0.152635089188442,0.174794307821865,-0.495231932519297,0.189961754142413,0.382562231175478
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,33054,-0.167334659406895,0.16915119572075,-0.498871003019565,0.164201684205775,0.322561558946501
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29086.Experienced a violent or sexual assault,33088,-0.198605186765896,0.135121291623718,-0.463442918348382,0.0662325448165907,0.141642180404817
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29087.Experienced a life-threatening injury or illness,33096,-0.288337835346422,0.0944359716231807,-0.473432339727857,-0.103243330964988,0.00227011784181081
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29088.Experienced a marital separation or divorce,33097,-0.127243296810761,0.0858315587151855,-0.295473151892525,0.0409865582710023,0.138247583135921
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29089.Experienced the death of a spouse or partner,33106,-0.102362867957861,0.135774987401674,-0.368481843265142,0.163756107349421,0.450919161427729
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,33093,-0.0659504412737286,0.106245288770736,-0.274191207264372,0.142290324716915,0.534787636052259
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29091.Frequency of drinking alcohol,33100,0.759877841253524,0.072962987004762,0.61687038672419,0.902885295782857,2.93516492183896e-25
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,32143,0.566673047905673,0.0823100517232897,0.405345346528026,0.728000749283321,6.2170235500257e-12
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,32156,0.589538903675692,0.0826488937565528,0.427547071912849,0.751530735438536,1.06423601945422e-12
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29104.Ever used cannabis,33090,0.180665275919271,0.0968069160308432,-0.00907627950118123,0.370406831339724,0.0620390082566783
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29108.Ever thought that life not worth living,33049,-0.166005063452314,0.0871106038588892,-0.336741847015737,0.00473172011110889,0.056722723829147
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29109.Ever contemplated self-harm,33062,-0.158652774725497,0.112627149224437,-0.379401987205394,0.0620964377543988,0.158971055937102
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29111.Ever self-harmed,33081,-0.0783343377682073,0.177047090046168,-0.425346634258696,0.268677958722282,0.658174584529325
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,33088,-0.258331232192759,0.121642357576501,-0.496750253042702,-0.0199122113428171,0.0337222105805598
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32126,-0.0108974262287966,0.0226260444813443,-0.0552444734122314,0.0334496209546381,0.630080166047599
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32126,-0.020081684527083,0.017970242943421,-0.0553033606961882,0.0151399916420222,0.263814551422871
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32126,0.00985903921759533,0.0186087152679848,-0.0266140427076548,0.0463321211428455,0.596259548299056
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32126,-0.0133443572932298,0.0246814441969429,-0.0617199879192379,0.0350312733327783,0.588754072831886
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,33079,0.0469914718525465,0.0810823592842966,-0.111929952344675,0.205912896049768,0.562230697466123
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X29153.Pain or discomfort today,33090,-0.160344780084574,0.0776367270044672,-0.31251276501333,-0.00817679515581865,0.0389204796766369
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29154.Anxiety or depression today,33090,-0.288625324413192,0.093943804148743,-0.472755180544729,-0.104495468281656,0.00213021569596504
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29166.Frequency of confiding in someone close,32883,0.0913976472010481,0.0752228612468044,-0.0560391608426885,0.238834455244785,0.224388413156359
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,33062,-0.0129260974435499,0.00571012430102682,-0.0241179410735625,-0.00173425381353733,0.0236147968515461
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,33062,0.0141291445444056,0.00568554207967402,0.00298548206824454,0.0252728070205667,0.0129691106126168
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,33062,0.0226557088117595,0.00712411468759722,0.00869244402406899,0.0366189735994501,0.0014769023793869
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,33062,-0.0125473052491293,0.00838753022116928,-0.0289868644826211,0.0038922539843625,0.134701618841747
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,33062,0.000796142428129692,0.0129571419793501,-0.0245998558513965,0.0261921407076559,0.951006712680768
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,33062,0.00860287909868254,0.0061166486616426,-0.00338575227813697,0.020591510475502,0.159618557142181
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,33058,-0.0120531974934228,0.00668258117766799,-0.0251510566016521,0.00104466161480643,0.0713151445981108
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,33058,0.00193777202046314,0.00945659936050327,-0.0165971627261233,0.0204727067670495,0.83764530356155
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,33058,0.0195678976778418,0.0153532138667944,-0.0105244015010752,0.0496601968567587,0.202513242318214
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,33058,0.0196718795467288,0.0151088010758774,-0.00994137056199096,0.0492851296554485,0.192943999646054
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,33058,0.0406002385426628,0.0202227348152312,0.000963678304809534,0.080236798780516,0.0447093483716809
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,33058,0.00854894132044299,0.00990981395965771,-0.0108742940404861,0.0279721766813721,0.388339085694036
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29171.Frequency of feeling 'in tune' with people,32900,0.269806614439835,0.0912944521381494,0.0908694882490622,0.448743740630608,0.00313125531314735
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29172.Freuency of feeling that lacks companionship,33017,-0.0942712724398931,0.0838086805240674,-0.258536286267065,0.069993741387279,0.260686750927687
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29173.Frequency of feeling left out,32972,-0.153878209804589,0.0861427606087688,-0.322718020597775,0.0149616009885982,0.0740813152838753
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29174.Frequency of feeling isolated from others,33001,-0.122422513240798,0.0887248502543448,-0.296323219739314,0.0514781932577177,0.167682106409209
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29175.Tendency to bounce back quickly after hard times,33075,0.199351914331683,0.0754270767982381,0.0515148438071366,0.34718898485623,0.00823200549245729
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29176.Ability to make it through stressful events,33075,-0.257958221410664,0.0738672867756417,-0.402738103490922,-0.113178339330407,0.000481333010543859
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29177.Quick recovery from stressful events,33075,0.175792237777589,0.0748679281879631,0.0290510985291813,0.322533377025997,0.018893969779573
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29178.Hard to snap back when something bad happens,33075,-0.244518169214861,0.0736698778310802,-0.388911129763778,-0.100125208665944,0.000906564436531314
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29179.Comes through difficult times with little trouble,33075,0.220762984833149,0.0748878255105097,0.0739828468325503,0.367543122833748,0.00320727246189659
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29180.Tendency to take a long time to get over setbacks,33075,-0.230174501164546,0.0743493523440941,-0.375899231758971,-0.0844497705701218,0.00196838103885619
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29181.General happiness,33018,-0.14801538555462,0.077595262040386,-0.300102099153777,0.00407132804453658,0.056483093241177
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29182.Belief that own life is meaningful,32932,0.0657402429634476,0.0771134796322033,-0.0854021771156709,0.216882663042566,0.393951946081711
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28245,0.0808200289731374,0.106759832140333,-0.128429242021914,0.290069299968189,0.449074630189388
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2946.Father's age,32687,0.0026839747104294,0.00424186683397573,-0.00563008428416304,0.0109980337050218,0.526923546560306
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2966.Age high blood pressure diagnosed,28405,0.00821556150423622,0.00701844948925943,-0.00554059949471226,0.0219717225031847,0.241834460824554
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30000.White blood cell (leukocyte) count,47660,-0.00868292875746023,0.00181982668117411,-0.0122497890525615,-0.00511606846235898,1.841309453583e-06
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47660,0.00859936841757442,0.00214700821235075,0.00439123232136696,0.0128075045137819,6.21322438480196e-05
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30020.Haemoglobin concentration,47660,0.0229803326117296,0.00228410623514967,0.0185034843908363,0.027457180832623,9.16856667614334e-24
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30030.Haematocrit percentage,47660,0.0229360539079709,0.00224034016984392,0.0185449871750768,0.0273271206408649,1.51024838928115e-24
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30040.Mean corpuscular volume,47660,0.0149645155333988,0.00181408397761448,0.0114089109372744,0.0185201201295232,1.67802873340388e-16
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47659,0.0130560013511245,0.00181701612156626,0.0094946497528546,0.0166173529493943,6.89811344723804e-13
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47659,0.000472322518593309,0.00178078755460879,-0.00301802108843991,0.00396266612562653,0.790832750622151
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47660,-0.00792860744947677,0.00173252878513703,-0.0113243638683454,-0.00453285103060818,4.75614263884885e-06
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30080.Platelet count,47660,0.00522318836758749,0.00183334712726867,0.00162982799814089,0.00881654873703408,0.00438958217400498
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30090.Platelet crit,47660,0.00290080373951141,0.00187833451552443,-0.000780731910916479,0.0065823393899393,0.122517141076453
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47660,-0.00529880810764497,0.00176490635349107,-0.00875802456048747,-0.00183959165480247,0.00268211190710221
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30110.Platelet distribution width,47660,-0.0111210910608523,0.00174979490301644,-0.0145506890707645,-0.00769149305094006,2.11302656940007e-10
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30120.Lymphocyte count,47627,-0.000300879717929779,0.00185186987424803,-0.00393054467145593,0.00332878523559637,0.870934402569233
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30130.Monocyte count,47627,-0.00472241520024679,0.00185293664904754,-0.00835417103237997,-0.00109065936811362,0.0108215098445499
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30140.Neutrophill count,47627,-0.00927944726686091,0.00180394496527172,-0.0128151793987935,-0.00574371513492833,2.71121246380321e-07
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30150.Eosinophill count,47627,-0.0062393940601081,0.00176321191170644,-0.00969528940705271,-0.00278349871316348,0.000402942280912278
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30160.Basophill count,47627,-0.0414718377861898,0.0492650882771535,-0.138031410809411,0.0550877352370311,0.399902854190486
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30170.Nucleated red blood cell count,47627,0.188336695498574,0.210482878559554,-0.224209746478152,0.600883137475299,0.370911668562743
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30180.Lymphocyte percentage,47627,0.00819814959723359,0.00182002385109713,0.00463090284908323,0.011765396345384,6.68715382749808e-06
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30190.Monocyte percentage,47627,0.00166739861070895,0.00182651471052222,-0.00191257022191459,0.0052473674433325,0.361312077202139
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30200.Neutrophill percentage,47627,-0.00634040663718227,0.00179188963799944,-0.00985251032766118,-0.00282830294670336,0.000403340823220616
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30210.Eosinophill percentage,47627,-0.00315014458886816,0.00173905257665061,-0.00655868763910335,0.00025839846136704,0.0700893722807486
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30220.Basophill percentage,47627,0.000700397094787184,0.00173770797533031,-0.00270551053686022,0.00410630472643459,0.686909185278929
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30230.Nucleated red blood cell percentage,47627,0.195517054784984,0.210384715185118,-0.216836986977847,0.607871096547816,0.352726971226366
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30240.Reticulocyte percentage,47225,-0.0016121280390299,0.0018695292125915,-0.00527640529570924,0.00205214921764944,0.388521592423828
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30250.Reticulocyte count,47225,-0.000332664623535867,0.00191883412872598,-0.00409357951583878,0.00342825026876705,0.862363601182875
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30260.Mean reticulocyte volume,47225,0.010274943426937,0.00180408804450211,0.0067389308597129,0.0138109559941612,1.24584649771817e-08
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30270.Mean sphered cell volume,47225,0.0163728090182552,0.00180854114558745,0.0128280683729038,0.0199175496636066,1.49628195308983e-19
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30280.Immature reticulocyte fraction,47225,0.0030090768823277,0.00188416391823122,-0.000683884397405484,0.00670203816206089,0.110271291736958
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47225,0.000355304515323349,0.00191098034266666,-0.00339021695630331,0.00410082598695001,0.852502935829702
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30300.High light scatter reticulocyte count,47225,0.00135136735088441,0.00194477027743459,-0.00246038239288739,0.0051631170946562,0.487142128663615
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30500.Microalbumin in urine,31003,-0.0099650327381629,0.00336440763777226,-0.0165592717081965,-0.00337079376812928,0.00306755761130806
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47766,-0.00525593308499854,0.00184991329089625,-0.0088817631351552,-0.00163010303484188,0.00449852079145293
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30520.Potassium in urine,47716,0.00224054423783631,0.00171269785057333,-0.00111634354928743,0.00559743202496004,0.190819490203232
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30530.Sodium in urine,47715,-0.00267493903852861,0.00178534824705692,-0.00617422160276017,0.000824343525702943,0.134075573101262
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30600.Albumin,45308,0.0321436223829549,0.00191273637844511,0.0283946590812024,0.0358925856847073,5.66995480989621e-63
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30610.Alkaline phosphatase,47292,-0.00270375323121008,0.00181737482103406,-0.00626580788043684,0.000858301418016672,0.136836993257626
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30620.Alanine aminotransferase,47281,0.0107853514868112,0.00192388219385236,0.00701454238686059,0.0145561605867619,2.09344388925506e-08
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30630.Apolipoprotein A,45177,0.0885753981324261,0.00201784085601161,0.0846204300546434,0.0925303662102089,0
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30640.Apolipoprotein B,47136,0.0198874366460303,0.00184466775485934,0.016271887846506,0.0235029854455546,4.90121064705505e-27
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30650.Aspartate aminotransferase,47214,0.0104030967942451,0.00180196705300186,0.00687124137036143,0.0139349522181287,7.87700923406966e-09
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30660.Direct bilirubin,43589,-0.000491084717833233,0.00196419391593657,-0.00434090479306891,0.00335873535740245,0.80257568399556
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30670.Urea,47286,0.00486045862662693,0.00189897261994632,0.00113847229153214,0.00858244496172172,0.0104878995936873
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30680.Calcium,45305,0.0262636430442804,0.00186632356176488,0.0226056488632212,0.0299216372253395,8.88307705514909e-45
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30690.Cholesterol,47296,0.0463496142610241,0.00187764263367322,0.0426694346990246,0.0500297938230236,7.70479644830137e-133
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30700.Creatinine,47290,-0.00688678804875115,0.00231226333523815,-0.0114188241858179,-0.00235475191168437,0.0029007758922121
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30710.C-reactive protein,47218,-0.0151626486430639,0.00196767093124947,-0.0190192836683129,-0.0113060136178149,1.35097197554028e-14
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30720.Cystatin C,47292,-0.0297608752372079,0.00212101981864093,-0.0339180740817441,-0.0256036763926717,1.51738460857603e-44
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30730.Gamma glutamyltransferase,47287,0.0190082469738484,0.00195822154875645,0.0151701327382857,0.022846361209411,3.10340538478933e-22
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30740.Glucose,45273,0.00155655561294897,0.00191397088998416,-0.00219482733141997,0.00530793855731792,0.416078153503882
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47123,-0.0133225666759981,0.00190406709241487,-0.0170545381771313,-0.00959059517486498,2.68786380596161e-12
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30760.HDL cholesterol,45287,0.0980663587270792,0.00212256160131859,0.0939061379884947,0.102226579465664,0
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30770.IGF-1,47186,0.0133260296154027,0.00186525807855858,0.00967012378142791,0.0169819354493775,9.30899184886211e-13
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30780.LDL direct,47245,0.0289685522684271,0.00186513349616367,0.0253128906159463,0.0326242139209079,3.95167315830052e-54
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30790.Lipoprotein A,42662,-0.000168083590959407,0.00198184387436208,-0.00405249758470908,0.00371633040279026,0.932411977599811
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30810.Phosphate,45254,0.00349114743266393,0.00187667585239234,-0.000187137238025065,0.00716943210335292,0.0628592660203974
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30830.SHBG,45099,0.00103216892672889,0.00217830399453259,-0.00323730690255498,0.00530164475601277,0.635618432805143
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30840.Total bilirubin,47207,0.00987117716276774,0.00183927848849592,0.00626619132531574,0.0134761630002197,8.08761218450885e-08
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30850.Testosterone,45400,0.0133476560655385,0.00311218425768115,0.0072477749204835,0.0194475372105936,1.80391630049387e-05
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30860.Total protein,45292,0.0234693877498876,0.00190034814387363,0.0197447053878953,0.0271940701118799,6.40045760840971e-35
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30870.Triglycerides,47278,-0.0224552440562744,0.00187907098368537,-0.0261382231842978,-0.0187722649282511,8.07118835419684e-33
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30880.Urate,47267,0.00922652487642351,0.00228365831518505,0.00475055457866081,0.0137024951741862,5.35672075756238e-05
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30890.Vitamin D,46335,0.00388833917959544,0.00196931603394193,2.84797530692624e-05,0.00774819860612162,0.0483414850568144
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3137.Number of measurements made,46420,-0.0807021426446841,0.0565350646340575,-0.191510869327437,0.0301065840380685,0.153458135248466
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3143.Ankle spacing width,37728,-0.0158053409821232,0.00322803245706332,-0.0221322845979673,-0.00947839736627908,9.87693229934839e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37727,0.00431773154407434,0.00247012609895717,-0.000523715609881704,0.00915917869803038,0.0804895844011984
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3146.Speed of sound through heel,37728,0.00513734310213073,0.00240660763161077,0.000420392144173614,0.00985429406008785,0.0328044367093415
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37728,0.00502736017224849,0.00242759314090627,0.000269277616072199,0.00978544272842477,0.0383843819975221
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3148.Heel bone mineral density (BMD),37718,0.00559149943359431,0.00243307676386213,0.000822668976424528,0.0103603298907641,0.0215698480013925
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X3526.Mother's age at death,33842,0.000880998842286771,0.00328522644292612,-0.00555804498584843,0.00732004267042197,0.788574085319305
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X3581.Age at menopause (last menstrual period),29542,0.00539977948275352,0.0045076318463367,-0.00343517893606641,0.0142347379015734,0.230998367363674
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29474,0.00202359089680949,0.00410446984064332,-0.00602116999085142,0.0100683517844704,0.622016847754554
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4100.Ankle spacing width (left),31721,-0.00760853325969118,0.00427283118756977,-0.0159832823873279,0.000766215867945572,0.0750038009922648
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4101.Heel broadband ultrasound attenuation (left),31721,7.96495149473376e-05,0.00326094225640325,-0.00631179730760303,0.00647109633749771,0.98051398242939
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4103.Speed of sound through heel (left),31721,0.00186127725914833,0.00318581759787828,-0.0043829252326931,0.00810547975098977,0.559076634746469
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",31721,0.00123510548592411,0.00321352897509759,-0.00506341130526717,0.00753362227711538,0.700732765309267
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4105.Heel bone mineral density (BMD) (left),31714,0.00180904769086867,0.00322251815323418,-0.00450708788947032,0.00812518327120766,0.574556551856901
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",31721,0.00124076059061187,0.00321356880360895,-0.00505783426446166,0.00753935544568541,0.699432672642386
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4119.Ankle spacing width (right),31711,-0.00474854268434075,0.0041870265709949,-0.0129551147634907,0.00345802939480925,0.256783639459029
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4120.Heel broadband ultrasound attenuation (right),31711,0.000629136990852707,0.00328831547819394,-0.00581596134640743,0.00707423532811284,0.848275915557275
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4122.Speed of sound through heel (right),31711,0.00334960195974112,0.00319475244889173,-0.00291211284008667,0.00961131675956891,0.294454412044842
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",31711,0.00240546148693083,0.00322969732412584,-0.00392474526835582,0.00873566824221747,0.456418125844059
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4124.Heel bone mineral density (BMD) (right),31703,0.00190263369975313,0.00323789524944498,-0.00444364098915903,0.00824890838866529,0.556808096274497
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",31711,0.00240543360783631,0.00322971945506191,-0.00392481652408504,0.00873568373975765,0.456426430256589
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4194.Pulse rate,31986,0.00269323489172792,0.00312747367560443,-0.00343661351245675,0.0088230832959126,0.389178917179362
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4195.Pulse wave reflection index,31986,-0.000824589867464001,0.00304999813210511,-0.00680258620639001,0.00515340647146201,0.786892099661065
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4196.Pulse wave peak to peak time,31981,0.00165890333703368,0.00326471630101447,-0.00473994061295467,0.00805774728702204,0.61137532523795
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4198.Position of the pulse wave peak,31986,0.00157133721365672,0.00313878515897,-0.00458068169792448,0.00772335612523792,0.616652459279925
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4199.Position of pulse wave notch,31986,-0.00205443946069506,0.00308673006583,-0.00810443038972187,0.00399555146833174,0.50570393972247
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4200.Position of the shoulder on the pulse waveform,31986,-0.00302885415943493,0.00321455192962555,-0.009329375941501,0.00327166762263114,0.346101810321117
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4269.Number of triplets attempted (left),31854,-0.138874228017609,0.259917723510833,-0.648312966098841,0.370564510063622,0.593148375238354
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4270.Volume level set by participant (left),31772,0.0386607441831466,0.0757284920694955,-0.109767100273065,0.187088588639358,0.609702986029193
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4276.Number of triplets attempted (right),31864,-0.0928563143059457,0.259382448252769,-0.601245912881373,0.415533284269481,0.720360276683091
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4277.Volume level set by participant (right),31774,-0.0236156651303779,0.0766952547697139,-0.173938364479017,0.126707034218261,0.758154663962287
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X4288.Time to answer,32009,0.00219588432777493,0.00356966006478554,-0.00480064939920473,0.00919241805475459,0.538471373213513
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X4290.Duration screen displayed,32009,0.00202759406304645,0.00312880613628968,-0.00410486596408132,0.00816005409017422,0.516976813272188
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X46.Hand grip strength (left),48373,0.0124616458053154,0.0024653786219534,0.00762950370628673,0.0172937879043441,4.34263471776969e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X47.Hand grip strength (right),48353,0.0122315000425556,0.00244667723119026,0.00743601266942273,0.0170269874156885,5.79569674042396e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X48.Waist circumference,48423,-0.00656845048200546,0.00387190551505983,-0.0141573852915227,0.00102048432751181,0.0898154946986817
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X4803.Tinnitus,31810,-0.239131969655324,0.0926689449063179,-0.420763101671707,-0.0575008376389408,0.00988358237925835
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X4825.Noisy workplace,31938,-0.21191201624582,0.103490094076672,-0.414752600636097,-0.00907143185554346,0.0406260868529565
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X4836.Loud music exposure frequency,31886,-0.0846787984785419,0.111953290546812,-0.304107247950293,0.13474965099321,0.449445911285934
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X49.Hip circumference,48419,0.00651640435306774,0.00305958545473044,0.000519616861796073,0.0125131918443394,0.0331953628063691
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X50.Standing height,48394,-0.00727974442588762,0.0024297514794068,-0.0120420573255249,-0.00251743152625029,0.00273742515438132
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X5057.Number of older siblings,31258,-0.209232861113379,0.0803661617969141,-0.366750538235331,-0.0517151839914276,0.00924630669369922
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X51.Seated height,48276,-0.00506128789883589,0.00225136273292144,-0.00947395885536191,-0.000648616942309863,0.0245787172525133
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5181.Ever had eye surgery,29376,-0.144232310368104,0.193848633556208,-0.524175632138272,0.235711011402065,0.456880320132512
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5186.Duration visual-acuity screen displayed (right),29366,0.00862955586025671,0.00388250222669845,0.00101985149592775,0.0162392602245857,0.0262779201744399
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5188.Duration visual-acuity screen displayed (left),29364,0.00726946665919471,0.0038504491072942,-0.000277413591101918,0.0148163469094913,0.0590848235889658
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5190.Duration at which refractometer first shown (right),29313,0.00667239848378981,0.00380851755718734,-0.000792295928297367,0.014137092895877,0.0798356263087866
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5193.Duration at which refractometer first shown (left),29311,0.00754870613737938,0.00382523514166934,5.12452597074683e-05,0.0150461670150513,0.0485008232548481
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5199.logMAR, initial (right)",29342,-0.23934145047017,0.0960440576137652,-0.42758780339315,-0.0510950975471907,0.012732053257349
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5200.Final number of letters displayed (right),29342,-0.920448604086867,0.802528763783968,-2.49340498110345,0.65250777292971,0.251458416963651
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5201.logMAR, final (right)",29296,-0.0131145204634875,0.00367016860956486,-0.0203080509382347,-0.00592098998874038,0.000355600724968786
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5202.Number of rounds to result (right),29342,0.0483393294195994,0.0896134952728023,-0.127303121315093,0.223981780154292,0.589618898257723
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5206.logMAR, initial (left)",29341,-0.289559158034195,0.0957489498992988,-0.47722709983682,-0.101891216231569,0.00250488077668531
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5207.Final number of letters displayed (left),29341,-1.01151017999587,0.746453413421036,-2.4745588703011,0.451538510309359,0.175445335745322
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5208.logMAR, final (left)",29298,-0.0121799449355913,0.00363990426205948,-0.0193141572892279,-0.0050457325819547,0.000824749048537848
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5209.Number of rounds to result (left),29337,-0.0810224940682994,0.0901107344589888,-0.257639533607917,0.0955945454713186,0.368615761451172
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29130,0.00550641875101336,0.00384119841818363,-0.00202233014862654,0.0130351676506533,0.15176980122473
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29130,0.0061246287397177,0.00378029450925577,-0.0012847484984236,0.013534005977859,0.105260764957277
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5256.Corneal hysteresis (right),29130,-0.00157823541090322,0.00384732482225594,-0.00911899206252485,0.00596252124071842,0.681663949260089
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5257.Corneal resistance factor (right),29130,0.00233957256782935,0.00377606082884192,-0.00506150665670081,0.00974065179235952,0.535560983087625
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29108,0.00411418783053102,0.00386086025934186,-0.00345309827777903,0.0116814739388411,0.286647062931924
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29108,0.00440179917224223,0.00378589611558909,-0.00301855721431239,0.0118221555587968,0.24501078136115
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5264.Corneal hysteresis (left),29108,-0.00262268145018966,0.00383925670295407,-0.0101476245879796,0.00490226168760031,0.494559789615216
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5265.Corneal resistance factor (left),29108,0.00079086290020985,0.00377514810176212,-0.00660842737924391,0.00819015317966361,0.834072399399154
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29175,-0.166047980040404,0.356273496833514,-0.864344033834092,0.532248073753284,0.641185319852283
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48345,-0.00916842681571883,0.0104042234903261,-0.0295607048567579,0.0112238512253202,0.378206522441998
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48345,-0.0261456198005988,0.0115451487567662,-0.0487741113638604,-0.0035171282373371,0.0235434087425403
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48345,0.0257141244931228,0.0286237788546981,-0.0303884820620855,0.0818167310483311,0.369008697202115
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48345,-0.00209528621396878,0.00483223333976915,-0.0115664635599163,0.00737589113197876,0.664578270113934
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48345,0.00587291729370756,0.00433886599590123,-0.00263126005825885,0.014377094645674,0.175889155214141
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36076,0.00115334640464876,0.0049849266678474,-0.00861710986433215,0.0109238026736297,0.817033749966008
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36076,0.0151469954741797,0.0173627121536384,-0.0188839203469515,0.0491779112953109,0.383014715465402
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36076,0.0127960257176975,0.00852912572001727,-0.00392106069353633,0.0295131121289314,0.133569280006049
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36076,-0.00262046487624351,0.00538558787721774,-0.0131762171155903,0.00793528736310327,0.626571897933798
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48413,-0.00377045795615927,0.00975418494052786,-0.0228886604395939,0.0153477445272753,0.699094417331999
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48413,-0.00377045795615927,0.00975418494052786,-0.0228886604395939,0.0153477445272753,0.699094417331999
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48413,-0.00306308893832215,0.00719828526939619,-0.0171717280663387,0.0110455501896944,0.670453822457523
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48413,-0.00872860537965491,0.0112180407329864,-0.0307159652163083,0.0132587544569985,0.436525553652767
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48413,-0.0406473622853665,0.0280467159561452,-0.095618925559411,0.014324200988678,0.147273989246652
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48413,-0.00811714000381516,0.0199423080819367,-0.0472040638444111,0.0309697838367807,0.683988679643874
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48413,-0.0211018849959585,0.0293541893869051,-0.0786360961942925,0.0364323262023754,0.472227047512077
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48344,-0.00151076238448797,0.00555870890973227,-0.0124058318475632,0.00938430707858727,0.785791196492023
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48344,-0.0286290579160429,0.00951791960448024,-0.0472841803408242,-0.00997393549126165,0.00263317077234933
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48344,-0.00229450235585217,0.00465953405006419,-0.011427189093978,0.00683818438227365,0.622418597176874
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48344,-0.0109506483644714,0.00870393620965809,-0.0280103633354012,0.00610906660645849,0.208358193033682
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48344,-0.0174943203239938,0.00760080435177247,-0.0323918968534679,-0.00259674379451981,0.0213637991227586
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48344,-0.0171196907160062,0.00614058344006519,-0.029155234258534,-0.00508414717347845,0.00530822622445709
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29320,-0.0843789225159475,0.0169414249221528,-0.117584115363367,-0.0511737296685281,6.53297921849591e-07
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29320,-0.0276099435446137,0.0149060771699897,-0.0568258547977935,0.00160596770856617,0.0640423082297135
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29320,-0.0704270645213151,0.0181468550322525,-0.10599490038453,-0.0348592286581002,0.000105274793914804
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29320,0.0620086878522914,0.0150882772397813,0.0324356644623201,0.0915817112422627,4.01933713620685e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48303,0.0204903466640947,0.0153266433338919,-0.00954987427033349,0.0505305675985229,0.181264374871172
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48303,-0.0142562226255756,0.0223349026490096,-0.0580326318176345,0.0295201865664833,0.523288638620963
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48303,-0.0552346460623005,0.0461534207645798,-0.145695350760877,0.035226058636276,0.231411059609383
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48303,-0.0021308629550654,0.0376844293999298,-0.0759923445789278,0.071730618668797,0.954908175851584
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48303,0.00150918017153308,0.0141426311872469,-0.0262103769554708,0.029228737298537,0.915018803008483
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48303,-0.00574456104949151,0.0181290827327486,-0.0412775632056787,0.0297884411066957,0.7513450110288
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48303,-0.000903460503304929,0.0074082444924363,-0.0154236197084801,0.0136166987018702,0.902936937405804
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32338,-0.0188739040506229,0.013982031747462,-0.0462786862756485,0.00853087817440275,0.177094210193351
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32338,-0.0508429673263103,0.0156499604995539,-0.081516889905436,-0.0201690447471847,0.00116360710020834
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32338,-0.0144659466186226,0.0200200063444045,-0.0537051590536555,0.0247732658164103,0.469961253761289
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32338,-0.000324339130909167,0.0060919210874763,-0.0122645044623627,0.0116158262005444,0.957541252879408
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",34228,-0.0196681822826423,0.00682588762229224,-0.0330469220223351,-0.00628944254294956,0.00396712369125255
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",34228,0.0179488032311651,0.00552704714683858,0.00711579082336146,0.0287818156389687,0.00116814859032773
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",34228,-0.00590981755388296,0.00546347620033459,-0.0166182309065388,0.00479859579877284,0.279413016738842
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",34229,0.00690997630736677,0.0132249255846947,-0.0190108778386348,0.0328308304533684,0.601335899244609
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",34229,-0.0113785122486799,0.00861538583544362,-0.0282646684861494,0.00550764398878962,0.18662389569548
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",34229,-0.00267494229241242,0.0108529269006301,-0.0239466790176473,0.0185967944328225,0.805321777568531
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48344,-0.00360145723789386,0.0129640293874604,-0.0290109548373162,0.0218080403615284,0.781165283460818
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48344,-0.0219037425691697,0.00835570063595767,-0.0382809158156467,-0.00552656932269267,0.00876202340589758
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48344,-0.0430263193040233,0.0259977514488221,-0.0939819121437147,0.00792927353566808,0.0979369975222078
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48344,-0.0205102160353211,0.00946957543506421,-0.0390705838880469,-0.00194984818259523,0.0303279442454969
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48344,-0.0131535920667917,0.010458675544026,-0.0336525961330827,0.00734541199949929,0.208522097384357
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48344,-0.0489258725367265,0.0114653655962081,-0.0713979891052945,-0.0264537559681586,1.98618013852827e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48344,0.00755564565317973,0.00372651579054267,0.000251674703716084,0.0148596166026434,0.0426184159705917
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27579,-0.042869172398099,0.0120481305191398,-0.066483508215613,-0.0192548365805851,0.000378125579440362
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27579,-0.0336165571831297,0.0154158395687538,-0.0638316027378871,-0.00340151162837228,0.0292717465053263
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27579,0.0292270757128943,0.0113390876974992,0.00700246382579574,0.0514516875999928,0.00998848466744521
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27579,0.0193245647530784,0.00949878621113917,0.000706943779245673,0.0379421857269112,0.0419796072807884
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48460,-0.0179535299533836,0.00399659752033622,-0.0257868610932426,-0.0101201988135246,7.08106509540661e-06
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48460,-0.0305947410436335,0.0117033497204171,-0.053533306495651,-0.00765617559161605,0.00894946436127198
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48460,-0.00802065944906709,0.00402753785561558,-0.0159146336460736,-0.000126685252060554,0.0464419529237773
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48460,-0.006208908937595,0.00392016674153317,-0.013892435751,0.00147461787581002,0.113243450523867
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48460,-0.0229617639899334,0.00568606321543345,-0.034106447892183,-0.0118170800876839,5.40138674380399e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48460,-0.00247680019295655,0.00579577793395009,-0.0138365249434987,0.00888292455758563,0.669131365113542
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48460,-0.011662451522403,0.00432317760988949,-0.0201358796377864,-0.00318902340701965,0.00698768939426281
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48460,-0.0318145171534156,0.0121549616638173,-0.0556382420144976,-0.00799079229233362,0.00886540904932004
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40493,0.0146868883380849,0.00427609149212088,0.00630574901352793,0.0230680276626418,0.000594761480181481
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40493,0.0181091409275046,0.00448990071640405,0.0093089355233527,0.0269093463316566,5.52432139570571e-05
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40493,-0.0215023698630668,0.00536199191298396,-0.0320118740125154,-0.0109928657136182,6.0946250142766e-05
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40494,-0.00612520598578116,0.00735914827254161,-0.0205491365999627,0.00829872462840039,0.405237249788685
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40494,-0.0107527722461011,0.00475178913113723,-0.02006627894313,-0.0014392655490721,0.0236553574131887
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48252,0.00722647517976065,0.00442324686855442,-0.00144308868260601,0.0158960390421273,0.102324469285214
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48252,0.0026570979823811,0.00347459261212893,-0.00415310353739161,0.0094672995021538,0.444444403191326
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48252,0.00371194179178689,0.00414448716762054,-0.00441125305674938,0.0118351366403232,0.370457344462258
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48252,0.00957575181052782,0.00645363973081004,-0.00307338206185987,0.0222248856829155,0.137881438890426
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48267,0.00924585611251153,0.00380208811524944,0.00179376340662263,0.0166979488184004,0.0150318180601125
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48267,0.0162767693448965,0.00525869279278022,0.00596973147104723,0.0265838072187457,0.00196894738492342
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48344,0.00760098061803014,0.00402507710385693,-0.000288170505529452,0.0154901317415897,0.0589832483890938
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48344,0.0142689146544932,0.00497250207993075,0.00452281057782891,0.0240150187311575,0.00411389449821184
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48344,-0.00504294403037502,0.0073864388846414,-0.0195203642442722,0.00943447618352212,0.494783876477816
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48344,-0.00701327012997866,0.00874334630376278,-0.0241502288853537,0.0101236886253964,0.422487548597053
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48344,-0.0282648436862109,0.00847981137998878,-0.0448852739909889,-0.0116444133814328,0.000859827685730849
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48344,-0.0142387057095998,0.012404625412023,-0.0385517715171648,0.0100743600979653,0.251039829057699
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37728,0.00502750512136193,0.00242760405642172,0.000269401170775353,0.0097856090719485,0.0383796710732571
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X864.Number of days or week walked 10+ minutes,48003,0.0981015374346733,0.0434137331274796,0.0130106205048134,0.183192454364533,0.0238494328109632
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X874.Duration of walks,44809,0.00351642021827026,0.00180345111755714,-1.83439721417327e-05,0.00705118440868224,0.0512098966562827
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47352,0.0671033836315483,0.0424968408059701,-0.0161904243481531,0.15039719161125,0.11434481784372
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X894.Duration of moderate activity,42036,0.0763129522843536,0.0513343539688602,-0.0243023814946125,0.17692828606332,0.137141429104835
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X90087.No-wear time bias adjusted average acceleration,29265,0.00864979807626233,0.00359669459946719,0.00160027666130663,0.015699319491218,0.0162089835415087
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47367,0.193718777424038,0.0439329387501533,0.107610217473738,0.279827337374339,1.04107532993409e-05
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X914.Duration of vigorous activity,37687,0.0055708018002838,0.00229139695969395,0.00107966375928365,0.0100619398412839,0.0150622956539666
